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Abstract Healthcare processes are by nature complex,
mostly due to their multidisciplinary character that re-
quires continuous coordination between care providers.
They encompass both organizational and clinical tasks,
the latter ones driven by medical knowledge, which
is inherently incomplete and distributed among peo-
ple having different expertise and roles. Care pathways
refer to planning and coordination of care processes re-
lated to specific groups of patients in a given setting.
The goal in defining and following care pathways is to
improve the quality of care in terms of patient satisfac-
tion, costs reduction, and medical outcome. Thus, care
pathways are a promising methodological tool for stan-
dardizing care and decision-making. Business process
management techniques can successfully be used for
representing organizational aspects of care pathways in
a standard, readable, and accessible way, while support-
ing process development, analysis, and re-engineering.
In this paper, we introduce a methodological frame-
work that fosters the integrated design, implementa-
tion, and enactment of care processes and related deci-
sions, while considering proper representation and man-
agement of organizational and clinical information. We
focus here and discuss in detail the design phase, which
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encompasses the simulation of care pathways. We show
how Business Process Model and Notation (BPMN)
and Decision Model and Notation (DMN) can be com-
bined for supporting intertwined aspects of decision-
intensive care pathways. As a proof-of-concept the pro-
posed methodology has been applied to design care
pathways related to Chronic Obstructive Pulmonary
Disease (COPD) in the region of Veneto, in Italy.
Keywords Care Pathways · Decision Modeling ·
Methodological Framework · Business Process Model
and Notation · Decision Model and Notation ·
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1 Introduction
Healthcare systems are among the most complex and
challenging organizational environments [1]. Healthcare
organizations are becoming more and more fragmented
into specialized and integrated functional units, which
cooperate and exchange information to provide primary,
secondary, and specialist care. Healthcare organizations
operate by enacting a wide range of processes with dif-
ferent characteristics and requirements, spanning from
those capturing clinical procedures, such as diagnosis
and treatment, to those representing organizational and
administrative tasks, such as examination planning and
patient transfer [2]. Yet, clinical and organizational pro-
cesses are not independent, but rather complementary
and intertwined.
Among the many kinds of healthcare processes, care
pathways received increasing attention in the last years,
as they consider both organizational requirements and
clinical tasks. Care pathways have been defined in slightly
different ways, according to different perspectives. Here
we consider two widely acknowledged definitions. The
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first one specifies that “A care pathway is a complex
intervention for the mutual decision-making and orga-
nization of care processes for a well-defined group of pa-
tients during a well-defined period” [3], while in [4] in-
tegrated care pathways are defined as “structured mul-
tidisciplinary care plans which detail essential steps in
the care of patients with a specific clinical problem.”
Both definitions contain some common elements that
characterize care pathways. Among them, we underline
here the relevance related to the definition of care pro-
cesses/plans, to the multidisciplinarity of such plans,
the focus on specific groups of patients, and the decision-
making aspects related to such processes.
Thus, the computer-based design and management
of care pathways needs to be supported by method-
ologies and technologies, where all the considered as-
pects are suitably addressed. In this context, the need
to design and enact standard and reliable healthcare
processes, able to reduce the occurrence of exceptional
events that would compromise the quality and the ef-
ficiency of organizational and clinical outcomes, is not
new to the domain of healthcare process management [1,
2, 5].
Among existing technologies, business process sys-
tems emerged as a leading technology also in the health-
care domain [2, 6–10].
According to recent reports, the global Business Pro-
cess Management (BPM) market is accounted for $5.51
billion in 2015 and is expected to reach $ 17.96 billion
by 2022 [11], and $ 23.04 billion by 2024 [12].
Healthcare is among the main application domains
(Verticals, in the report terminology) of BPM technol-
ogy, while process modeling (per se) is one of the main
focuses of BPM tools [12]. Moreover, patient monitoring
in hospitals is underlined as one of the leading applica-
tions of BPM solutions in the healthcare industry. The
widely increasing healthcare-based regulations are in-
dicated as one of the leverages to increase the business
process management market growth in the healthcare
industry [12]. To complete to picture, among the key
players in this market we find Oracle, Microsoft, IBM,
SAP, and many others [11].
Among the plethora of existing business process lan-
guages [13], the Business Process Model and Notation
(BPMN 2.0) is currently the leading standard for pro-
cess design, developed by the Object Management Group
(OMG) [14]. BPMN provides a consolidated graphical
notation used to outline process activities, their logi-
cal and temporal ordering, and the resources respon-
sible for their execution. BPMN diagrams are suitable
to design, visualize, and document processes at differ-
ent levels of abstraction and according to different per-
spectives (process structure, interaction between pro-
cesses, and so on), thus meeting the needs of various
categories of users and fostering both process imple-
mentation and re-engineering. BPMN is currently sup-
ported by numerous process engines [15–17] that allow
stakeholders to actively monitor executable process at
run-time and support the interaction with knowledge
workers through domain-specific client and invoked ap-
plications.
Indeed, Business Process Management (BPM) sys-
tems provide rich development environments that in-
tegrate design with process simulation, which encom-
passes techniques used to walk through a process in
a step-by-step manner in order to check whether the
process actually behaves as desired [18]. In BPM, sim-
ulation is the most commonly used approach for quanti-
tative process analysis [19], as it enables the identifica-
tion of shortcomings and procedural bottlenecks, thus
allowing process managers to assess quality, check con-
formance, and to progressively tune organizational out-
comes.
Recently, the OMG proposed the Decision Model
and Notation (DMN 1.1) standard [20] to complement
BPMN for supporting decision design, management and
implementation, according to the well-known separa-
tion of concerns principle [21]. DMN diagrams are meant
to model decisions by representing input information,
the used knowledge models, and their requirements for
decision logic. Such explanatory diagrams portray the
structure of one or more decisions and can be linked
to one or more processes or activities, depending on
the scope of decision-making. Thus, coupling BPMN
processes and DMN diagrams could be beneficial to
support the integrated design of decision-intensive care
pathways, where complex clinical and organizational
knowledge for decision-making needs to be represented.
Despite the presence of such advanced models and
software tools, at the best of our knowledge, only few
attempts have been made to manage care pathways
through the integrated use of BPMN and DMN and,
even more important, no attention has been paid to pro-
pose/extend development methodologies for the specific
context of care pathways. Thus, according to the de-
picted scenario, in this paper we propose a new me-
thodological framework to support the integrated de-
sign, implementation, and enactment of decision-inten-
sive care pathways under an organization standpoint in
order to foster the modeling and re-engineering of care
pathways and related decision-making through proper
information management and data re-use. The method-
ology defines both the main phases of process develop-
ment, which are based on BPM best practices [18], and
the widely known and adopted modeling languages and
tools to be used. In detail, we show how the DMN no-
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tation can be used to complement BPMN with the goal
of increasing support towards decision-making, hence
improving its suitability for healthcare process model-
ing and enactment. For each phase, relevant informa-
tion sources are also highlighted. Within the proposed
methodology, we will mainly focus on the design phase.
The main novelties, specific for the management
of care pathways, of the proposed methodological ap-
proach are:
– supporting the integrated design of care pathways
and decisions, based on conjunct use of the standard
BPMN and DMN languages;
– strongly integrating care pathway simulation within
the design phase, to support agile development;
– proposing a classification of the main kinds of infor-
mation involved in different phases of process and
decision development, and investigating the role of
data-based indicators;
– using and possibly extending BPMN modeling con-
structs to represent complex temporal behaviors/
constraints in care pathways;
– illustrating meaningful aspects of clinical decision-
making and evaluating their scope and impact on
the overall care pathway.
Moreover, as a further added value, we show a real-
world application of the proposed approach to the de-
sign of care pathways for Chronic Obstructive Pulmonary
Disease (COPD), within a regional context.
The presented methodological framework extends the
approach introduced in [9] and tackles several new origi-
nal issues. This paper illustrates a more general method-
ology that encompasses all the phases of a typical busi-
ness process life-cycle, thus considering also process im-
plementation and enactment. Moreover, the role of sim-
ulation within the design phase is explicitly discussed.
In addition, connection points with existing formalisms
are highlighted, as the methodology aims to provide
a main standard core that can be extended and inte-
grated with context-specific decision support systems
and tools, suitable for dealing with complex clinical as-
pects. Information management is now included in the
methodological approach and a classification of data
that are relevant for process execution is presented. As
for the application to the clinical domain of COPD, the
goal of this paper is to illustrate process and decision
design for care pathway development, thus covering all
the aspects related to requirements analysis, modeling,
and simulation. In detail, primary, specialist, and sec-
ondary care of COPD have been studied and modeled
exhaustively, with the help of stakeholders. Specifically,
the presented BPMN and DMN diagrams describe not
only diagnosis and assessment of COPD patients, but
also ordinary and extraordinary care. Finally, real data
have been obtained from currently enacted healthcare
processes and they have been used for process simula-
tion in order to analyze as-is organizational procedures
from a re-engineering perspective.
The remainder of the paper is organized as follows.
Section 2 introduces the fundamentals of the BPMN
and DMN standards, elaborating on their integration.
Section 3 discusses the proposed methodological frame-
work. Section 4 explains important aspects of COPD
treatment and management and illustrates how the in-
troduced methodology is applied to the design and man-
agement of care pathways for COPD in the region of
Veneto, in northern Italy. Section 5 discusses related
work, considering proposals belonging to the domains
of BPM and clinical guidelines development. Finally,
Section 6 sketches some conclusions and presents fu-
ture work.
2 Background: modeling processes and related
decisions
In this section, the Business Process Model and No-
tation [14] and the Decision Model and Notation [20]
standards are introduced, in turn. Then, the integra-
tion of decision and process management is discussed,
with particular focus on the new insights provided by
the combined use of BPMN and DMN.
2.1 Business Process Model and Notation
In general, a business process (BP) is defined as “a set
of activities that are performed in coordination in an
organizational and technical environment” [18].
The Business Process Model and Notation (BPMN
2.0) was developed under the OMG umbrella as a stan-
dard language for graphically representing business pro-
cesses [14]. Born as a general purpose language, the
notation is suitable for modeling processes in multiple
application domains and at different levels of abstrac-
tion, thanks to its extensible meta-model organized in
layers. BPMN provides a set of basic elements meant
to be understood by both process designers and prac-
titioners, without extensive training. Yet, the notation
includes more advanced constructs and multiple kinds
of diagrams that allow expert users to express complex
concepts, such as message-based communication, event-
processing, and exception handling.
In BPMN, a process is represented by means of a
graphical diagram, which is mainly composed of activi-
ties, sub-processes, and events. These are connected by
a sequence flow that denotes the causal relations be-
tween them and is routed by gateways [14]. The basic
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elements of a process diagram are activities, events, and
gateways. Besides, swimlanes are used to represent or-
ganizational aspects and process participants, whereas
data artifacts outline process-related information.
– Activities represent work that is carried out during
process execution. BPMN provides two main ele-
ments for describing activities, namely, tasks and
sub-processes. Tasks are atomic units of work that
cannot be broken down to a finer level of abstrac-
tion. Graphically, they are depicted as rectangles
with rounded corners, enclosing the name of the ac-
tivity. A marker can be added to detail the type of
task, which is associated to a well-defined behavior
(e.g., “user tasks” denote that work is assigned to a
human performer). Conversely, sub-processes repre-
sent compound activities, whose internal detail may
(expanded sub-process) or may not (collapsed sub-
process) be shown. Collapsed sub-processes are rep-
resented as tasks decorated with a “+” maker. Ex-
panded sub-processes consist of an enlarged border
that contains all the sub-process elements.
– Events represent facts that occur instantaneously
during process execution. Graphically, they are de-
picted as circles and may contain a marker that
diversifies the kind of event trigger (e.g., message,
timer, signal, etc). Depending on their behavior,
events can either throw a trigger or catch a result.
BPMN defines three kinds of events, based on their
position in the process. Start events (single border)
initiate a process instance, end events (single thick
border) conclude it, and intermediate events (double
border) are located at any point between the process
start and end. Intermediate events can be attached
to the boundary of an activity and they can ei-
ther be interrupting or non-interrupting. Interrupt-
ing boundary events interrupt the activity they are
attached to, whereas non-interrupting boundary e-
vents initiate a parallel process path.
– Gateways control the divergence and convergence of
the sequence flow, according to data-based condi-
tions or event occurrence. Graphically, they are de-
picted as diamonds with an internal marker that dif-
ferentiates their routing behavior. The “+” marker
is used for parallel branching, while a “×” identi-
fies an exclusive gateway, i.e., a point in the process
where a condition must be evaluated in order to
choose one path out of more.
– Swimlanes are containers identifying organizational
aspects, such as the organization structure (depart-
ments, roles) and resources (process participants).
Pools are used to represent resource classes or roles,
such as, for instance, “Pharmaceutical supplier”. In
BPMN roles are used to classify process participants
according to their skills, knowledge and responsi-
bilities within the process. Lanes are used to sub-
partition an organization into functional units or in-
dividual process participants, and can be arbitrarily
nested to denote role hierarchy.
– Data artifacts represent information that is pro-
duced or consumed during process execution. In par-
ticular, volatile data are represented through data
objects, which can be exchanged between activities.
Graphically they are depicted as paper documents,
with a bent corner. Persistent data sources are mod-
eled as data stores, which are associated to activi-
ties and can be referenced from different parts of the
same process.
Other specific BPMN elements used in this paper,
will be explained later, when needed.
To introduce the BPMN notation, we employ a sim-
ple example taken from the clinical domain of Chronic
Obstructive Pulmonary Disease (COPD) [23]. In partic-
ular, let us consider the 6-Minute Walk Test (6MWT),
one of the clinical tests used to objectively evaluate
the functional exercise capacity in COPD patients [22].
6MWT is a practical test that “measures the distance
that a patient can quickly walk on a flat, hard sur-
face in a period of 6 minutes” [22]. The goal for the
patient is to walk as far as possible in the given time
frame, assisted by a trained technician. This test is typ-
ically used to evaluate exercise tolerance in chronic res-
piratory disease and heart failure, and it allows physi-
cians to monitor pulmonary and cardiovascular func-
tions, among others. 6MWT is typically performed in
a dedicated hospital hallway, as timely and appropriate
emergency measures must be enacted in case of com-
plications. 6MWT must be immediately stopped if the
patient shows signs of chest pain, intolerable dyspnea,
leg cramps, staggering, diaphoresis, and pale or ashen
appearance [22]. In this scenario, the trained technician
must take blood pressure, pulse rate, and oxygen satu-
ration Oxygen should be given, when needed.
A simplified version of the the main steps of 6MWT
is depicted in the BPMN process diagram of Fig. 1.
The goal of Fig. 1 is to exemplify how BPMN can be
used for providing a standard representation of clinical
procedures and of resources allocated to activities.
After being approved by a physician, the test is con-
ducted in a Respiratory Diseases Unit, represented as a
BPMN pool and it is carried out by a Trained Tech-
nician, depicted as a lane. First of all, the technician
should Allow the patient to sit on a chair to rest for at
least 10 minutes before the test starts. This temporal
span is represented by an intermediate timer event. A
couple of parallel gateways is employed to denote that,
during this time frame, the technician must Check pa-







































































Fig. 1 BPMN diagram summarizing some preliminary stages for the 6-Minute Walk Test, simplified and adapted from [22].
tient clothing and Evaluate relative contraindications. The
evaluation of contraindications is a decision about the
conduct of the test, based on the current values of the
patient vital parameters. The output of the decision is
used by the following exclusive gateway Can the test be
performed?. If the test is not believed to put the patient
at risk, pulse dosimetry can optionally be performed.
Exclusive gateway Perform pulse oximetry? is used to
represent this option. If it is performed, the physician
must Measure oxygen saturation, otherwise this task is
skipped. If measured, the value of oxygen saturation is
recorded in the patient Medical Record, portrayed as a
data store. Finally, 6MWT is performed. This is rep-
resented by means of a collapsed process, as individual
steps are not detailed.
However, if the patient experiences dyspnea, chest
pain, leg cramps, staggering, diaphoresis or pale ap-
pearance, the 6MWT must be immediately interrupted
[22]. In Fig. 1, this is captured by boundary interrupt-
ing conditional event Stop test, which encodes the afore-
mentioned conditions and generates an exception flow
that leads to task Assist patient.
Then, the depicted process is concluded by a simple
end event.
In general, BPMN can be used in various organi-
zation domain for documentation, analysis, and stan-
dardization purposes. In healthcare working environ-
ments, resources are often having complementary ex-
pertise and are loaded with heterogeneous tasks and
responsibilities. In this setting, process modeling tech-
niques are useful to improve coordination among differ-
ent functional units, support communication between
participants, and provide overall activity standardiza-
tion, especially in terms of organization aspects.
BPMN is supported by several (open-source) pro-
cess modeling tools and customizable engines [15–17]
and it is widely used in the context of business manage-
ment. The main advantage of using BPMN for health-
care process modeling is the fact that it is a well-main-
tained consolidated standard, complemented by other
standard notations for decision modeling [20], case man-
agement [24], and process exchange [25]. Moreover, as
healthcare processes are often monitored by adminis-
trative staff and information technology (IT) experts,
it is likely that these users are already familiar with the
notation.
Being a graph-oriented process modeling language,
BPMN allows combining flow objects almost arbitrar-
ily, thus leading to the definition of hardly readable and
complex process diagrams [26]. Large and articulated
models are difficult to be used and understood by less
trained users and they have proven to be more error-
prone. Nevertheless, structural restrictions and model-
ing guidelines can be applied to increase readability and
prevent undesired execution deadlocks [27]. A BPMN
process is said to be well-structured if for every split
node, i.e., a node with multiple outgoing edges, there is
a corresponding merge node, i.e., a node with multiple
incoming edges, such that the set of nodes delimited by
the split and the join nodes form a Single-Entry-Single-
Exit (SESE) region, and these regions within the pro-
cess are properly nested [28]. The previously discussed
process of Fig. 1 is an example of well-structured di-
agram. Structured processes have also proven to en-
hance modularity, which is the ability to decompose
the process into smaller reusable components. These
often correspond to process sub-regions having specific
properties defined over them, which is desirable under
a re-engineering standpoint.
In addition, comprehensible diagrams can be used
for documentation purposes and as a starting point for
communicating with clinicians, during interviews or re-
engineering interventions.
2.2 Decision Model and Notation
In business process design, decision-making covers a
crucial role. Process gateways and conditional events
often encode data-based operational decisions, whereas
decision activities encompass more complex non-oper-
ative decision-making. Decisions affect the process flow
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and, consequently, they impact both the performance
of the process and the quality of its (business) out-
comes. However, important decisions often remain hid-
den within process diagrams and BPMN is misused for
decision modeling, despite data-based preconditions of
BPMN elements are hard to understand [29, 30]. For
these reasons, business process modeling must be prop-
erly complemented with decision design.
To respond to this need, the OMG recently devel-
oped the standard Decision Model and Notation (DMN
1.1) [20]. DMN has been proposed as a standard nota-
tion to bridge the gap between the high level business
logic, represented in processes, and decision implemen-
tation, typically specified in terms of decision logic. The
notation supports the design of both human and au-
tomated decision-making, capturing both decision re-
quirements and decision logic. Together, these two lev-
els provide a complete decision model, which comple-
ments a process diagram by detailing the decision-mak-
ing carried out in process tasks [20].
The decision requirements level is modeled by means
of a Decision Requirement Graph (DRG), which may
be linked to one or more tasks belonging to one or mul-
tiple business processes. A DRG represents the main
elements involved in a decision-making domain and the
dependencies between them. As DRGs may be large
and complex, they can split into one or more Decision
Requirements Diagrams (DRDs). DRDs may be used
to show partial views of the whole decision domain,
focusing on areas of interest for a specific user or goal.
These diagrams define which decisions are made in pro-
cess tasks, which are their interrelationships, and their
requirements for decision logic.
The main elements forming a DRD are introduced in
the following list.
– Decisions portray the act of determining an out-
put from a number of inputs, using logic defining
how the output is retrieved from the inputs. Deci-
sions may reference one or more knowledge models.
Graphically, a decision is depicted as a rectangle,
labeled with the decision name.
– Business knowledge models denote functions that
encapsulate business knowledge, such as business
rules, decision tables, or analytic models. They are
illustrated as rectangles with clipped corners.
– Input data represent information used as an input
by one or more decisions. When enclosed within a
knowledge model, input data represent the param-
eters to the knowledge model. Graphically, they are
depicted as ovals.
– Knowledge sources identify an authority for a busi-
ness knowledge model or a decision, such as a per-
son responsible for managing the represented knowl-
edge, or a published document enclosing it. They are
depicted as a shape having three straight sides and
a wavy one.
Three kind of dependencies are defined between the
presented elements, in the form of requirements. An
information requirement, depicted as a simple arrow,
represents any input data (or decision output) that is
used as input to a decision. Graphically, an informa-
tion requirement is depicted as a solid-line arrow with
a filled arrowhead. A knowledge requirement denotes
the invocation of a business knowledge model by a de-
cision or by another knowledge model. Graphically, it
is a dashed-line arrow, having an open arrowhead. Fi-
nally, an authority requirement depicts the dependence
of a DRD element on another DRD element that acts
as a source of guidance or knowledge. This may denote
the fact that a business knowledge model is consistent
with a published document, or that a a specific person
is responsible for a certain decision. Graphically, it is
represented by a dashed line with a filled circular head.
Decision logic completes the (executable) descrip-
tion of decisions, by allowing oneto define them in suffi-
cient detail to support validation and/or automation. In
general, decision logic can be modeled in several ways,
which translate business expertise into business rules,
analytic models, or other formalisms. DMN defines dif-
ferent kinds of value expressions to associate decision
logic with elements of a DRG.
A literal expression represents decision logic as text
that describes how an output value is derived from a set
of inputs. Literal expressions may be represented with
a formal, and possibly executable language, or they
can be written in plain English. Formal expressions can
be specified with the Friendly Enough Expression Lan-
guage (FEEL) [20], which translates if/then/else data
structures and calculations into executable expressions.
A decision table is a tabular representation of a set
of input and output values, organized into rules that
describe how a given input relates to one or more corre-
sponding outputs [20]. The Simplified FEEL (S-FEEL)
is a subset of FEEL, used for defining expressions in
decision tables.
An invocation is a tabular representation of how de-
cision logic, represented by a business knowledge model
is invoked by a decision, or by another business knowl-
edge model.
Tabular representations of decision logic are called
boxed expressions.
As an example, let us consider the 6-Minute Walk
Test, introduced in Section 2.1. In some clinical situ-
ations, this test may be contraindicated for patients
considered at risk. Relative contraindications are evalu-
ated by a trained technician right before test execution.
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These are a resting heart rate of more than 120 bpm, a
systolic blood pressure of more than 180 mm Hg, and a
diastolic blood pressure of more than 100 mm Hg [22].
The technician performing the test must measure the
patient vital parameters and decide whether the test
can be conducted safely.
A simple DRD representing the decision about the
conduct of the 6MWT is shown in Fig. 2.
The main decision regarding the Conduct of 6MWT
is based on the assessment of Relative Contraindications,
which are encoded as rules within a business knowl-
edge model. This model is invoked by the main deci-
sion, which passes input data Arterial Blood Pressure
and Heart rate as parameters for the model. Finally, the
Trained technician is indicated as a knowledge source, to
represent the authority responsible for deciding about
the conduct of 6MWT. The described DRD of Fig. 2 is
linked to task Evaluate relative contraindications of the
BPMN process of Fig. 1. In general, there may be a one-
to-one correspondence between a BPMN process task
and a DMN decision. Yet, this is not mandatory, as the
same decision can refer to multiple tasks and can be
used across processes.
Fig. 3 depicts the decision logic corresponding to
business knowledge model Relative Contraindications, by
using a decision table. In Fig. 3, input and output val-
ues are arranged into columns, whilst rules correspond
to rows. At the top left corner of a decision table, a
couple of attributes can be present, one to denote the
kind of hit policy for the table, the other to indicate
its completeness. A hit policy specifies how overlapping
rules are handled, that is, how output values must be
returned in case more than one rule match input data.
In the presented case, character U is used to denote a
unique hit policy for the table, meaning that no over-
lapping rule is allowed, that is, all rules are disjoint and
only a single rule can be matched [20]. A completeness
indicator can be optionally used to specify whether at
least one rule in the table matches a possible input con-
figuration. Symbol C denotes a complete table (DMN








Fig. 2 Decision Requirement Diagram representing the de-
cision for the conduct of the 6-Minute-Walking-Test, with re-
lated input data and invoked business knowledge model Rel-
ative Contraindications.














1 - - > 120 False
2 > 100 > 180 - False
3 > 100 > 180 >120 False










Fig. 3 Labeled decision table portraying the decision logic
underlying decision Conduct of 6MWT of Fig. 2.
symbol “-” is used to denote that the value of a cer-
tain input is irrelevant for the final decision, that is,
the decision can be made even if that input value is
unknown.
2.3 On linking BPMN and DMN diagrams
Whereas operational processes have received plentiful
attention, decision modeling in business process man-
agement has been scarcely addressed to date. How-
ever, decision-making constitutes an important aspect
of knowledge representation in business processes.
BPMN and DMN standards address decision-mak-
ing from different and complementary perspectives. On
the one hand, business process diagrams allow one to
identify specific decision activities, which are usually
captured as user or business rule tasks.
User tasks are defined as typical workflow activi-
ties, which are assigned to a human performer through
the use of worklists and are executed with the assis-
tance of a software application. Instead, business rule
tasks provide a mechanism for the process to inter-
act with a business rule engine for decision manage-
ment [14]. On the other hand, DMN defines which are
the decisions made in process tasks, which are their
inter-relationships and their requirements for decision
logic. DMN can be used independently from BPMN to
model a domain of decision-making without any refer-
ence to business processes. The two standards are in-
tended to be used according to the separation of con-
cerns paradigm [21, 31], that is, by allowing designers
to keep decision logic in a dedicated decision model
and process logic in a process diagram. Decoupling pro-
cess and decision diagrams can also be advantageous
in contexts where process and decision managers have
different roles and expertise. Indeed, despite allowing
the use of gateways for drawing multi-criteria decisions,
BPMN is not suitable for decision-design for many rea-
sons. First of all, a process gateway is not entitled to
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properly “decide”, but it rather specifies which path is
taken by a process instance, based on existing process
data or event occurrence. Secondly, decisions in BPMN
are often drowned into complex and hardly-readable di-
agrams and their formalization can become quite cum-
bersome [29]. Last but not least, slight changes of de-
cision logic may have a strong impact on the whole
process diagram, thus requiring substantial re-design.
DMN compensates BPMN by supporting the de-
sign of both operational decisions, which are made in
day-to-day business processes, and strategic decisions,
which are typically more complex and harder to rep-
resent. The easiest way to connect a DMN model to
one or more BPMN processes is by allocating different
kinds of decision-making to separate process tasks [20].
According to its level of automation, a decision can be
discerned into human or automated. Human decisions
are performed by organization personnel and are usu-
ally described informally at a high level, using natural
language rather than decision logic. Conversely, auto-
mated decisions require that decision logic is formally
specified. For these decisions it should also be possible
to validate that a process uses the results of decisions
only in tasks or gateways following a decision activ-
ity [20]. In healthcare, partial automation is more com-
mon, since, despite being formalizable into automatic
rules, most decisions are reviewed or validated by per-
sonnel. A typical example of partially automated deci-
sion is drug dosing based on a patient’s age and weight.
This is performed by a physician, who takes into ac-
count some fixed thresholds suggested by clinical indi-
cations. According to [20], human decision-making can
be enclosed in BPMN user tasks, whereas (partially)
automated decision making can be allocated to busi-
ness rule tasks.
3 The Methodological Framework
In this section, we present a new methodological frame-
work for supporting the seamless design, implementa-
tion, and enactment of healthcare processes and deci-
sions. We also tackle a few crucial aspects related to
the management of information relevant for the execu-
tion of both processes and decisions. In particular, the
methodology provides both a classification of the dis-
parate facets of process-related decision-making and a
qualitative analysis of the kinds of data involved in the
various phases of process development.
3.1 Overview
The proposed methodological framework, which extends
the methodology introduced in [9], is a general-purpose
approach grounded on standard BPM models and tools,
but it is presented with special attention to the require-
ments related to the management of care pathways. In
particular, we present a structured approach to delin-
eate the main phases of care pathway development and,
for each phase, we define which are the techniques and
tools to be used and how. In addition, we provide the
reader with an overview of which are the most impor-
tant challenges that can be encountered in each phase.
Finally, we suggest possible connection points with ex-
isting formalisms suitable to be used in the healthcare
domain.
The viewpoint of the methodology is intentionally
process-oriented, as the macro-steps portrayed in the
central part of Fig. 4 correspond to specific phases of
the business process life-cycle. Namely, we considered
DESIGN, IMPLEMENTATION, and ENACTMENT, the
latter one encompassing also performance analysis [18].
These phases constitute the core of the approach and
are connected to process-related information, which is
outlined at the top of Fig. 4. The mentioned life-cycle
phases are framed by a dashed line to highlight that
there is an open interaction and a continuous exchange
of knowledge and information between the phases of
process development and the organizational environ-
ment. The advancement from one phase to the next
one is shown in Fig. 4 by small light-blue triangles.
In real application environments it is common to
deal with incremental process development, followed by
iterative refinements and often with agile approaches,
i.e., non-completely planned and heavily involving final
users, in the related software development [32]. For this
reason, the depicted life-cycle has to be considered to
be continuous. That is, the output of the enactment
phase is re-used as an input for the design phase. This
iterative re-thinking and organizational change of both
the structure and the outcomes of a process is often
referred to as process re-engineering. Business process
re-engineering is commonly defined as the “radical re-
design of one or more aspects of a business process”,
aimed to improve process performance and to imple-
ment organizational changes [33]. In Fig. 4, the RE-
ENGINEERING of both processes and decision-making
is represented by thick curved light-blue arrows. A big
re-engineering arrow links the enactment and design
phases, denoting the need for process and decision re-
design, based on information retrieved from process ex-
ecution and analysis. Similarly, two smaller curved ar-
rows are used to represent local re-engineering steps,
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Fig. 4 Main steps of the proposed methodological framework. The Design phase has been exhaustively applied to the COPD
case study, as detailed in Section 4.
aimed at refining the design of process and decision di-
agrams, based either on insights provided by simulation
or on new requirements. In healthcare, process change is
often needed to improve compliance to standards state-
ments or to integrate health information systems [34].
Here, we will show how the presented methodologi-
cal approach for care pathways design and enactment,
even if applied partially, allows IT experts and care
providers to interact and address some complex chal-
lenges [1, 5, 35]. The methodology is directed to expert
process modelers, that is, we assume that a team of pro-
cess and IT experts, actively interacts with care provi-
ders and clinicians to deeply understand and analyze
the healthcare context. Indeed, as process development
is a time-consuming task that requires IT expertise, we
do not expect clinicians to directly model and maintain
the given care pathway.
Table 1 summarizes some important questions whose
answers need to be collected by process experts when
applying the introduced methodology for developing
healthcare processes.
3.2 Design: modeling processes and decisions
Reasonably, the development of decision-intensive health-
care processes begins with a DESIGN phase. This is or-
ganized into three main steps: REQUIREMENTS EN-
GINEERING, MODELING, and SIMULATION, depicted
in Fig. 4. With respect to process and decision design,
during Requirements Analysis a specific organizational
problem is studied, and process participants, final ob-
jectives, and performance goals are defined. The lat-
ter ones are usually determined with help of indica-
tors, established by teams of clinicians and healthcare
managers who meet regularly to assess process perfor-
mance. Among the indicators to consider in care path-
ways, in recent years Health Care Quality Indicators
(HCQIs) have been proposed by OECD state members,
as a way to assess, monitor, and compare the qual-
ity of healthcare systems both at regional and national
level [37]. As an example, cancer mortality rates and
the number admissions for asthma are quite traditional
quality indicators, to consider in related pathways. Re-
quirements engineering usually comprehends feasibility
studies and the analysis, definition, and specification of
requirements, aimed at understanding the studied do-
main and the role of the modeled pathway in the organi-
zational context. In the healthcare domain, process and
decision requirements related to care pathways stem ei-
ther from organizational documents, medical literature,
clinical guidelines, and local care policies, or they are
collected by process modelers through direct interac-
tion with both medical professionals and care managers.
Usually interviews with participants are conducted and
modelers are invited to observe how the organization
operates.
MODELING embraces both processes, data and de-
cisions, based on the previously identified requirements.
Process modeling allows one to filter out the irrelevant
10 Carlo Combi et al.






How does the healthcare organization operate?
Which are the final goals (clinical ones? related to healthcare
policies? related to monitoring quality of care?) and which is
their value?
Who are the clinical/healthcare final users of the modeled
care pathway?




Which and how many processes can be discerned?
Are the processes covering clinical or healthcare-
organizational aspects?
Which is the best modeling granularity that fulfills the goals
of care providers?
BPMN Diagram
Which are the main process aspects and how can they be
represented (roles, activities, etc.)?
Are there recurrent/known patterns? [36]
Which are the clinical/healthcare data that need to be avail-
able for the process to be executed? Where are they stored?
How are they exchanged?
Does the model require execution details?
Decision
Identification
Which and how many decisions can be discerned?
Are decisions operational or strategic (i.e., strongly based on
aggregated medical data)?
Do decisions influence the process flow? How?
DMN Diagram
Which data requirements are needed for decision-making?
Are these data coming from EHR/EMRs? Are they specific
to this activity?
Who is responsible for making the decision?
Does the decision need to be automated or is it made by a
human resource?





Is the process behaving as expected?
Which are the costs and the duration of the process?
Are the bottlenecks related to bad modeling or resource con-
sumption?
What aspects of the process need improvement?





How is the process enriched with information for execution?
How is the graphical model translated/enriched?
Are there organization constraints on execution?
Testing and
Deployment
Does the engine have access to all services, client, and invoked
application needed by the process?
How does the process interact with other systems?
How are instances grouped or synchronized (e.g., by patient,





Who executes process tasks?





Does the process conform to the expected objectives?
Are there process instances that cause bottlenecks?
Monitoring
Which is the current status of the process?
Are there unexpected shortages of resources?
Is there the need of sending alerts or managing exceptions?
Table 1 Summary of important questions that may be answered during each phase of the methodology shown in Fig. 4.
complexities of a real scenario, while providing a picture
of the considered healthcare environment, tailored to
spot improvements needed for re-engineering. Process
modeling begins with Process Identification, aimed at
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establishing the main process activities, their execution
order, and the chosen modeling granularity. During pro-
cess identification, the modeler decides which and how
many processes should be outlined, considering final ob-
jectives and possible implementation requirements. Be-
sides, it is crucial to ensure that the outlined processes
do not overlap and that the interactions between re-
sources correspond to reality. To this end, BPMN chore-
ography and collaboration diagrams can be employed to
explicitly represent message-based communication be-
tween multiple processes and resources [14]. Usually, at
this point, process elements are still defined at a quite
abstract level.
Conversely, step BPMN Diagram deals with the de-
sign of a more detailed process diagram, by making
use of process elements defined in the Business Pro-
cess Model and Notation standard. BPMN diagrams are
suitable to represent the process control flow with suf-
ficient detail and expressiveness, at different degrees of
structural complexity and support for automation [18].
In addition, BPMN partially tackles other aspects of
process modeling, such as the exchange of data pro-
duced and consumed during process execution and the
management of process roles and their interactions. In
particular, BPMN allows the designer to specify differ-
ent roles within a healthcare organization and to specify
which activities have to be performed by different roles,
through pools and swimlanes.
During this phase, process designers adapt the pro-
cess model to better suit the final design goals and to
meet the local requirements of the application context.
Designers can exploit existing patterns for modeling
control flow [36], data [38], and time [39], to capture
complex process aspects.
Similarly, decisions play a crucial role in process de-
velopment and enactment, and, thus, it is important to
understand how they affect both the process flow and
the organizational environment. Hence, decision model-
ing is carried out in parallel or in conjunction with pro-
cess modeling. Decision Identification deals with the dis-
covery of which are the decisions that affect the process
and its organizational landscape: During this phase,
modelers need to understand which are the relation-
ships between decision-making and the process flow,
and which are the repercussions of decision outputs on
the process flow.
A decision can be modeled by means of a DMN
Diagram, which addresses different aspects of decision-
making. In particular, decision requirement diagrams
represent the internal structure of a decision and its re-
lationships with other decisional steps. When needed,
decision logic can also be specified, by using boxed ex-
pressions or decision tables. Whenever decisions are ex-
plicitly represented in a BPMN model, a DMN dia-
gram can be associated to those process activities that
encompass decision-making. In Fig. 4, this connection
is represented through a simple double-headed arrow
that links BPMN Diagram to DMN Diagram. However,
according to the principle of separation of concerns [21,
40], it is beneficial to keep process and decision log-
ics separate, as these are usually supported by different
stakeholders, having distinct goals and expertise. We
distinguish two main types of decision:
– Operational decisions are usually expressed quanti-
tatively, in terms of process variables that are used
by process gateways to determine which path has to
be chosen. Usually, operational decisions are repre-
sented in BPMN as decision tasks (i.e., a task of type
user or business rule), whose result is used by a fol-
lowing gateway [29]. In the healthcare domain, op-
erational decisions concern daily activities, such as
drug dosing, identification of a specific vital param-
eter to measure, and scheduling of examinations.
– Non-operational decisions include more complex and
strategic decision-making, usually affecting high level
process objectives [41]. In healthcare, such decisions
are often expressed in the form of natural language
statements, based on medical evidence or profession-
als’ knowledge, and rely on qualitative assessment.
In a BPMN diagram, such decisions can be repre-
sented by a single decisional task, or they can span
over more process activities. Examples of complex
non-operational decision-making are clinical diagno-
sis and therapy planning, taking into account differ-
ent kinds of knowledge and, possibly, sub-decisions.
Usually DMN is used for supporting operational de-
cisions, and patterns have been proposed to ease the
extraction of such decisions from the process control-
flow [29]. As for decision logic, DMN supports the rep-
resentation of decision tables and logic formalisms that
can be easily mapped to the Friendly Enough Expres-
sion Language (FEEL). Decision tables can be con-
structed by using almost any principle, for instance
by using the approach presented in [42] when decisions
need to be extracted from textual guidelines. In addi-
tion, algorithms for analyzing the completeness, con-
sistency and non-redundancy of DMN decision tables
have been proposed in [43], and tools such as Signavio
currently support the verification of completeness for
decision tables containing numerical entries. Moreover,
DRDs can be useful to provide a compact and explana-
tory representation of non-operational decisions. In de-
tail, DRDs can be used for decision compliance and
management, as they allow managers to understand
which data must be used for decision-making, which
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are the required sub-decisions to be made, and who is
responsible for them.
As third and final step of the design phase, in Fig. 4
Process and Decision Simulation is connected to pro-
cess and decision modeling by means of dashed arrows,
meaning that, despite being specific for the design of
care pathways (as discussed in detail in Section 3.4),
useful, and cost-saving, it does not constitute a manda-
tory design step.
3.3 Dealing with process-related information and
knowledge
PROCESS-RELATED INFORMATION is represented at
the top of Fig. 4, and the relationships with the in-
troduced phases of process and decision development
are highlighted by solid lines, depicted with a rounded
arrowhead. During requirements engineering and mod-
eling, DOMAIN KNOWLEDGE is used to provide a clear
description of the relevant aspects of the modeled re-
ality, by considering peculiarities, critical aspects, and
goals of a specific healthcare organization. For instance,
a care pathway for treating patients affected by pneu-
monia must deal with medical knowledge related to
the management and treatment of pulmonary diseases,
bearing in mind that we are interested in data regarding
the organizational aspects of the treatment rather than
in clinical knowledge. Similarly, REFERENCE DATA help
to delineate the requirements for process compliance.
Examples of such data are reference values for med-
ical parameters, input values for medical instrumen-
tation, as well as administrative data regarding per-
sonnel salaries and skills, required duration of certain
procedures, and quality standards. Reference data are
strongly related to domain knowledge and local organi-
zation policies.
Then, OPERATIONAL DATA regarding process ac-
tivities, roles, and the organizational structure are also
gathered during requirements analysis. During process
and decision modeling, input and output data for pro-
cess activities and decisions must be identified, and
their structure, usage, and availability must be defined.
In general, operational data produced, consumed and
exchanged by process activities must be considered dur-
ing the design of a BPMN diagram, either to set activity
attributes or to define data artifacts. During process de-
sign, data-related aspects are usually expressed through
data stores and data objects. As BPMN is closely re-
lated to UML, some extensions can be adopted to en-
rich the graphical representation of data objects and
data stores, by adding to process representation the
direct reference to the UML database attributes that
are touched by readings and inserts/updates required
by each task. By adopting this solution, it is possible
to represent the direct connection that exists between
the conceptual model of the process and the conceptual
schema of the accessed database [44].
In healthcare, operational data are typically stored
within health information systems. Similarly, OPERA-
TIONAL DECISIONS are used in day-to-day operations
and must be defined to ensure that their input and out-
put data are used properly within the process. Process
and decision modeling deals also with non-operational
data that are used for decision support. This informa-
tion, often referred to as AGGREGATED DATA, can be
used to measure the performance of the process within
a specific application context and to make strategic de-
cisions during process execution. In healthcare, aggre-
gated data are extracted from data warehouses or deci-
sion support systems, to be used during process mod-
eling and re-engineering. A subset of both operational
and non-operational data, used to identify which are
the aspects of a process model that are interesting to
be analyzed during process execution, is represented by
CONFORMANCE DATA.
Finally, PROCESS METRICS AND KPIs are used to
quantify process and decision quality and productiv-
ity. Data-based Key Performance Indicators (KPIs), are
measurable values that assess the progress of care path-
ways towards the achievement of the organizational ob-
jectives.
In BPM, Key Performance Indicators (KPIs) are de-
fined to monitor process execution, evaluate the qual-
ity of process and decision outcomes, and quantify the
overall progress towards organizational goal achieve-
ment [19].
In this work, depending on their scope, we discerned
two kinds of pathway KPIs. Local KPIs correspond to
process and decision metrics and are mostly used to
measure activity execution times, costs, and resource
consumption. We refer to such indicators as “local”,
as they are extracted/used directly from/by multiple
instances of one process model. As an example, the ex-
pected mean time duration to complete a care pathway
related to the management of patients with breast can-
cer requiring a following chemotherapy is a local KPI,
as it is related to the specific pathways and to possible
“local” features of patients, reacting in different ways
to the given chemotherapies.
Conversely, global KPIs are used to evaluate the
strategic value of the performed (decision) activities
both quantitatively and qualitatively. Global KPIs can
be directly re-used in clinical decision modeling, to im-
prove decision quality, patient prognosis, and predictive
analytics. Usually, global KPIs rely on aggregated data
and their impact can affect several activities and pro-
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cesses. In addition, they can be used for organizational
and re-engineering purposes that go beyond the scope of
the defined processes. These indicators are rather based
on clinical and healthcare data, and provide a sum-
marized and focused overview of the modeled domain.
Global KPIs can have both a clinical or organizational
character. Continuing with the example related to the
oncological pathway, a global KPI could be the ratio be-
tween the number of patients concluding in a succesfull
way the pathway and those who stopped the pathway
for some health related issue. Such kind of global KPI
could be possibly used inside the pathway to finely tune
chemotherapy cycles as well as outside the pathway to
activate, for example, suitable prevention actions.
As already underlined pathway KPIs are strictly re-
lated to Healthcare Quality indicators, as we will show
in the application of the proposed methodology to COPD
patient management. Indeed, HCQIs may correspond
to some measure used to structure and evaluate the
considered pathway. As an example, the outcome indi-
cator coded as 13a “The proportion of patients with
estrogen receptor negative invasive carcinoma who re-
ceived adjuvant chemotherapy, out of the total number
of patients with the same diagnosis” is an acknowledged
quality measure of the process related to breast cancer
treatment [45]. This value could be both a result of
a general care pathway representing the overall man-
agement of patients with breast cancer and an indica-
tor used inside a more specific pathway for managing
chemotherapies, to estimate the percentage of patients
that have to be considered for the given pathway.
Although care pathway KPIs are used during pro-
cess analysis or simulation, they are defined during re-
quirements analysis and process identification, in order
to better tailor the process model to the final goals.
3.4 Integrating simulation in the design of care
pathways
Process simulation is one of the most popular and widely
used technique for quantitatively analyzing process mod-
els [19]. Simulation encompasses both the execution of
a model under hypothetical conditions in a defined sim-
ulation environment and the analysis of the execution
output [46].
During process design, SIMULATION can be used to
support the quantitative analysis of pathway models.
Specifically, Process and Decision Simulation promotes
the study of the execution of modeled pathways and
decisions in a realistic or ideal scenario, without re-
sorting to pathway and decision implementation. Being
faster and more flexible than process enactment, sim-
ulation tools and techniques foster pathway validation
and provide reliable estimates of resource consumption
and execution times. Indeed, process configuration and
enactment may be highly demanding, while stakehold-
ers are interested in obtaining prompt and reliable es-
timates of process behavior, associated costs, required
resources, and quality of outcomes. Simulation allows
one to validate a process behavior, by spotting bottle-
necks, and by evaluating resources costs and consump-
tion. Besides, the duration of the overall process and
of single activities can be estimated and ideal or worst-
case scenarios can be studied. Decision simulation is
often used to reproduce the outcomes of decision tables
given an arbitrary set of input values and to verify ta-
ble completeness. As previously mentioned, simulation
results can be re-used to promote process adaptation to
expected performance requirements. Moreover, simula-
tion can be used for what-if analysis to explore alter-
natives, eliminate inadequate re-engineering proposals,
and refine current as-is procedures.
Beside the continuous support to designers during
care pathway modeling, in the proposed methodology
we underline the importance of simulation for stake-
holders who are responsible for decision-making within
the healthcare organization. Indeed, simulation support
healthcare decision makers in resource allocation and
management. Through simulation, decision makers can
verify whether the resources associated to a care path-
way have been suitably considered, with respect to the
estimated number of patients and with respect to the
specified goals for the pathway (e.g., reach the end of
the treatment within 30 days since the admission of the
patient).
Both local and global pathway KPIs could be con-
sidered together with HCQIs to see their mutual inter-
actions in a “what-if” analysis context. As an exam-
ple, in the chemotherapy domain, the previously de-
fined indicator 13a is expected to be at least 80% [45].
This value could be used to distinguish the percent-
age of patients following a path of activities related to
chemotherapies from other patients receiving different
treatments. When simulating the same care pathway,
one could change the value of 13a to the target value of
90% in order to monitor the effects of such change on
the local KPIs of the pathway, such as its overall cost
or its average duration.
Moreover, simulation can provide healthcare deci-
sion makers with some evaluation of HCQIs related to
the considered pathway. As an example, in the design of
a care pathways for patients with acute stroke, we could
consider whether the HCQI Acute stroke mortality rate
is maintained low, according to the expected features of
patients, the expected results of the designed activities,
and so on. In this direction, simulation can be used to
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estimate, as a kind of decision-support what-if analysis
how HCQIs change with respect to different scenarios.
Finally, simulation results can also feed some indicators
that either are employed in external processes or sup-
port strategic decision making, or are used to obtain
more complex HCQIs.
3.5 Implementation and Enactment
Following design, the methodological framework deals
with IMPLEMENTATION, which can be realized in dif-
ferent ways, depending on which IT infrastructures are
already available in the organizational environment. Im-
plementation is realized in different steps, usually start-
ing from the automation of single processes and, then,
by realizing the coordination between them. When start-
ing from a single process, AUTOMATION is usually the
first step that is applied for implementation. Automa-
tion focuses on the selection of software and services for
process execution, encompassing both implementation
and deployment aspects. In Fig. 4, by Process Imple-
mentation we intend mostly process configuration, that
is, the integration of a process model with technical
information that facilitates enactment. Then, the en-
riched BPMN diagram is mapped into a formalism suit-
able for execution. Processes are executed by engines,
which link client applications, supports the distribution
of work among different process actors, and coordinates
activities. Most existing process engines support the di-
rect deployment of standard XML process descriptions,
generated by modeling tools, without the need of fur-
ther mappings.
Process automation is closely related to Testing and
Deployment. Traditional testing techniques from soft-
ware engineering can be used to test the automated
process, to see if it behaves as expected. During this
phase, integration and performance are tested for de-
tecting potential run-time problems. Finally, the sys-
tem is deployed in its target environment and com-
plementary actions, such as data migration and user-
training may be executed. In general one advantage of
using standard modeling languages is that process en-
gines can easily interpret them and, within healthcare
organizations, such systems may already be used by the
administrative staff.
The final phase of the introduced methodological
framework deals with ENACTMENT, which consists of
EXECUTION and PERFORMANCE ANALYSIS.
In detail, Process and Decision Execution encompasses
the actual run time of a decision-intensive process. This
is usually the result of the process engine interacting
with client applications. Execution constraints must be
observed, and execution exceptions arising from unex-
pected occurrences must be properly handled. In this
methodology, we do not explicitly deal with exception-
handling, as this topic depends on the kind of sys-
tem used for implementation and solutions have already
been proposed in the BPM community [47].
During and/or following process execution, perfor-
mance analysis may be carried out to monitor enact-
ment or to analyze how well the process is perform-
ing, compared to desired performance goals. In Fig. 4,
the relationship between process execution and perfor-
mance analysis is depicted by a double-headed dashed
arrow, meaning that the latter may be optionally per-
formed during or after process execution. Monitoring
allows one visualizing the current status of process and
activity execution, in order to be able to enact correc-
tive measures if the process is not behaving as expected.
During process monitoring, bottlenecks can also be de-
tected.
Analysis tools and algorithms can also be used to
verify specific properties, such as done for the satisfac-
tion of temporal constraints in [48].
Conformance Analysis is employed to verify the fit-
ness and appropriateness of a process with a given pat-
tern or organizational model, in order to check whether
the process is well-incorporated the organizational prac-
tice. Both structural and behavioral aspects can be an-
alyzed and the results of the analysis can be used for
re-aligning the process model to reality. In general, mul-
tiple cycles of monitoring and conformance analysis are
executed. In addition, formal methods, such as Petri
Nets, can be applied for analyzing process behavior [49].
During process enactment, conformance data and
process metrics and KPIs are used to monitor the status
of the running process and to analyze different execu-
tions. Usually, valuable execution data are gathered in
the form of EXECUTION LOGS, that is, long files that
contain information about events that have occurred
during process enactment. Examples of such data are
starting and ending times of activities, task duration,
role assignments, and message exchanges. Execution
logs are analyzed for process re-engineering and align-
ment, or for discovery and mining purposes.
3.6 Managing temporalities of care pathways
Even though a deep discussion related to the manage-
ment of temporal issues in care pathways is out of scope
with respect to the content of this paper, in the follow-
ing we will discuss the main temporal issues related to
care pathways. Besides, we will show how the proposed
methodology can be used to easily embed a suitable
management of such time aspects.
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Temporal aspects of care pathways are usually com-
plex and need to be suitably modeled, both in RE-
QUIREMENT, and MODELING phases. As an example,
in modeling preliminary stages for the 6-Minute Walk
Test in Section 2, we need to represent that the patient
as to rest for at least 10 minutes before executing the
test. Further temporal constraints among different ac-
tivities may also need to be represented. For instance, it
could be interesting to show that the efficacy of a ther-
apy must be evaluated two weeks after the treatment
has been prescribed, as in the management of COPD
that will be later discussed. Furthermore, periodicities
need to be considered, since some care-related activities
are inherently periodic, as, for example, the assessment
of some chronic pathology or the administration of a
given drug.
The representation of temporal constraints in BPM
systems have been considered in literature, also con-
sidering clinical processes [8, 50–53]. In general, the fo-
cus of such proposals is both to (i) design temporal
constraints in BP models and (ii) to verify some basic
properties of temporal BP models. In particular, the
concept of dynamic controllability has been introduced
and extensively studied. Suitable algorithms have been
proposed to verify at design time whether a process
model can be executed while satisfying all the given
temporal constraints and allowing activities performers
to take any possible duration within the range of the
allowed ones [8,52]. The proposed solutions can be ap-
plied also to suitably extended BPMN models, as they
use the most common BP constructs, as activity, sub-
process, gateways, and so on. Thus, from this point of
view, the proposed methodology is well suited to embed
tools and models for checking temporal features of BP
models.
Recently, modular BPMN-based temporal patterns
have also been proposed in [54, 55], explicitly focus-
ing on clinical tasks. The advantage of these BPMN
patterns is that temporal aspects are suitably repre-
sented and embedded within a sub-process that can be
edited by modelers and executed directly on a process
engine. Thus, such patterns can be seamlessly and di-
rectly specified within BPMN care pathways and suit-
ably dealt with in the proposed methodology.
Moving to the SIMULATION and EXECUTION of
time-aware care pathways, two different aspects arise:
The first one is related to updating temporal constraints
according to previously executed process tasks; The sec-
ond one deals with the runtime management of possible
constraint violations and of the related reaction poli-
cies. As shown in [10, 54] for some basic patterns, de-
signers can leverage exception handling of BPMN 2.0 to
specify suitable patterns for supporting different kinds
of reactions to constraints violation. As an example, if
a therapy duration exceeds its maximum duration, the
model designer could specify either that such therapy
must be immediately interrupted (strong policy) and
some other compensation actions could be enacted or
that the therapy will continue (weak policy), but some
other actions have to be done (sending a warning to the
physician) [10].
As a final comment, it is worth noting that pow-
erful solutions to support time-related aspects of care
pathways through BPMN are mainly based on the ex-
pressive power provided by the use of events, event-
related activities, and exception-handling mechanisms.
As an example, timer events can be used to specify ei-
ther a specific delay from their activation or a certain
time-date or a specific period of time within the process
model, to trigger some specific clinical activity or some
conditional path in the control flow.
4 Design and simulation of decision-intensive
care pathways for Chronic Obstructive
Pulmonary Disease
In this section, we apply the introduced methodology
to a real healthcare scenario, in order to discuss model-
ing choices and design challenges, and share the bene-
fits brought by the proposed approach in a real clinical
context.
The methodology discussed in the previous section
has been applied to support the design of diagnostic-
therapeutic care pathways for the management of Chron-
ic Obstructive Pulmonary Disease in the region of Ve-
neto, in northern Italy. The process and decision dia-
grams have been designed to provide a compact rep-
resentation of healthcare procedures aimed at easing
the understanding and improvement of as-is healthcare
pathways and of their organizational aspects. One of the
main modeling goals was the detection of pathway flaws
that led to undesired, yet reducible healthcare expenses.
Healthcare pathway implementation and enactment are
out of the scope of this paper that mostly focuses on
care pathway design and simulation. Hence, here we
will consider in detail the design of COPD-related care
pathways.
Requirements have been collected by analyzing tex-
tual documents authored by the Regional Healthcare
System of Veneto, including both regulatory standards
and organizational plans, and clinical practice refer-
ences. In addition, we directly interacted with the re-
gional board, composed of care managers and clinicians
responsible for the actuation of the care pathways, and
we were directly observing how care interventions have
been carried out in a few regional hospitals. Finally,
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standard American and European guidelines for COPD
management have been studied and used for process
compliance [23,56].
Among existing tools for process design and man-
agement, we chose the Signavio Business Transforma-
tion Platform, which integrates process modeling, de-
cision design, and simulation features for cost analy-
sis [17]. The web-based Signavio Process Editor has
been used for process design and simulation, as it guar-
antees full adherence to the BPMN standard and sup-
ports different kinds of process simulation and cost man-
agement on several user-defined scenarios. In addition,
it provides several functionalities that ease collabora-
tive design, diagram reviewing, and commenting. The
Signavio Decision Manager has been chosen to model
DMN diagrams and to simulate decision table execu-
tion.
In the remainder of this section, we introduce the
modeled clinical domain in Section 4.1 and we explain
the design of both processes and decisions with BPMN
and DMN in Sections 4.2 and 4.3. Then, we discuss the
re-use of information through indicators in Section 4.4
and present simulation results in Section 4.5.
4.1 Chronic Obstructive Pulmonary Disease (COPD)
The World’s Health Organization defines COPD as “a
life-threatening lung disease characterized by chronic
and not fully reversible obstruction of lung airflow, which
interferes with normal breathing” [57]. Despite being
both preventable and treatable, COPD global preva-
lence and socioeconomic impact remain significantly
high [58], thus making the disease one of the leading
causes of disability and death in developed countries.
Whereas COPD is often underdiagnosed in younger
patients, as respiratory abnormalities become notice-
able only when internal organ damage is already ad-
vanced [59], current diagnostic criteria may lead to over-
diagnosis in the elderly [60]. A major proportion of
COPD burden is represented by exacerbations, i.e., acute
and unexpected worsening of respiratory symptoms that
require a change in management.
In order to improve the management of COPD, in-
tegrated diagnostic and therapeutic care pathways have
been proposed at a regional scale, with the intent of im-
proving the effectiveness of COPD treatment, the pre-
vention of exacerbations, and the coordination between
different care providers. The development of such care
plans aims to standardize the critical steps of long-term
patient treatment and the overall decision process. In
particular, it is crucial to clarify which is the role of
each involved resource, which are the responsibilities,
and which is the optimal timing for intervention. Be-
sides, clinical, social, educational, and organizational
objectives are set by considering economical expenses
and resource availability.
The main goal of COPD diagnostic and therapeutic
care pathways is the improvement of primary care qual-
ity mostly by reducing costs, intended both as patient
lives and economical burden, related to misdiagnosis
and to the prescription of unnecessary medical exams
and treatments. The definition of such plans also en-
compasses a set of indicators that are defined to eval-
uate disparate aspects of the healthcare process, such
as its structure, clinical and organizational efficiency,
performance, progress towards the set final objectives,
and overall economic impact. Prevention measures, ed-
ucational programs, and counseling services are also
included in the care plan, with the aim of training pa-
tients to recognize symptoms worsening and to improve
the self-management of the disease in home care set-
tings.
The proposed methodology supported regional health-
care stakeholders to design COPD related decision-intensive
care pathways. Data used for the design and simula-
tion are based on official regional reports [61, 62] and
on other bibliographic resources provided by healthcare
stakeholders [63–65]. Previous research on the burden
of COPD in Italy has been presented in [63]. Data
regarding COPD expenses have been considered with
respect to those obtained by the interviews with re-
gional healthcare stakeholders, although the number
of patients affected by COPD in Veneto is increased
from 6.2% of 2003 to 8.5% 2015. The major sources of
expenses are hospitalization and oxygen therapy. The
problems highlighted in [63] are similar to those high-
lighted by the experts that worked on the care path-
ways: poor results of smoking cessation programs, lim-
ited use and access of spirometers in primary care, un-
derdiagnosis of COPD.
Such design phase is an initial step that should allow
to reach the definition of a region-wide standard man-
agement of COPD patients, after a deep re-engineering
phase. Healthcare stakeholders have been involved in
design phase of the methodology, with an agile ap-
proach. Healthcare stakeholders participated to the de-
sign together with BPMN designers, who asked ques-
tions highlighted in Table 1 to them during the design
meetings and collected answers in working and informal
documents. BPMN and DMN documents, integrated
with comments,together with simulation descriptions,
are the formal and final results of this iterative design
phase.
The modeled BPMN processes have provided health-
care professionals with a comprehensive and accurate
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overview of the COPD care pathways. After applying
the proposed methodology, improvements in common
understanding and cooperation have been noticed. In
earlier times, each resource used to work independently
and this fragmentation resulted in longer waiting times
for patients, miscommunication, and information over-
load. The standard definition of the care processes has
served to delineate everybody’s responsibility, while im-
proving information exchange, cooperation between re-
sources, and coordination between several processes.
Besides, from a technical point of view, the process
model has been used for validating the consistency and
efficiency of the proposed solutions, thus constituting a
sound trace for implementation.
4.2 Modeling COPD pathways with BPMN
In the assessment and management of patients with
COPD, three main intervention steps have been dis-
cerned, namely (i) COPD diagnosis and assessment, (ii)
ordinary management of stable COPD, and (iii) man-
agement of COPD exacerbations. These steps are de-
scribed in medical literature [23, 56], and are also be
identified in the as-is processes that are currently ap-
plied in Veneto. For each one of the aforementioned
steps, a BPMN process diagram has been designed, fol-
lowing the principles of well-structured process design
to lower diagram complexity and reduce the probability
of committing modeling errors [27,28].
The three phases included in the studied care path-
ways for the management of COPD are depicted in the
BPMN process diagram of Fig. 5, each instance of which
represents the treatment of a single patient. Each one of
these aspects of COPD management is represented as
a collapsed sub-process, which relates to the other pro-
cess elements as described in the following paragraph.
The overall care process begins in primary care with
the COPD Diagnosis and Assessment, during which prac-
titioners, organized in Primary Care Units (PCUs), have
to detect the disease and classify the patient according
to the most pertinent severity level. This assessment
phase is carried out only once and, then, any patient di-
agnosed with COPD enters a multidisciplinary program
for monitoring and managing the disease, which is en-
acted periodically, based on the assessed COPD stage.
The studied healthcare context of Veneto provides a
staging system based on three main levels of severity,
which is slightly different from the one presented in [23].
In particular, all patients having a spirometry-related
value FEV1 ≤ 50% are considered at high risk and be-
long to Stage 3 (i.e., there is no Stage 4). The general
practitioner is in charge of COPD diagnosis and of mon-
itoring and validating the decisions made by pulmonary
specialists.
General and pulmonary examinations considered in
the Management of Stable COPD are scheduled based
on the severity of the disease. For this reason, the sub-
process representing the ordinary management of COPD
is executed periodically. In BPMN, this periodicity is
expressed by setting a looping condition for the whole
Management of Stable COPD sub-process. In Fig. 5, this
is highlighted by a standard loop marker [14], depicted
at the bottom of the sub-process.
However, during ordinary COPD management, ex-
acerbations can occur. In the BPMN process of Fig. 5,
the occurrence of an exacerbation is represented by
means of non-interrupting boundary conditional event
Exacerbation Episode, which is triggered when an exac-
erbation occurs.
Non-interrupting boundary events allow the activity
to which they are attached to remain active and a new
a token is generated to drive a new flow, parallel to the
continuing execution of the activity.
Therefore, as event Exacerbation Episode is non-inter-
rupting, Management of COPD Exacerbations starts while
ordinary Management of stable COPD is still being per-
formed. Exacerbations must be promptly treated in or-
der to reduce the impact of the current worsening and
prevent the development of future episodes. In gen-
eral, the treatment of exacerbations does not affect the
intervention planned for the ordinary management of
COPD.
However, ordinary medical inspections must be re-
scheduled whenever the stage of the disease changes,
either due to the progression of the disease or to an
exacerbation episode. In Fig. 5 this is represented by
boundary interrupting signal event Re-schedule, which
is triggered by a corresponding signal event thrown ei-
ther within sub-process Management of Stable COPD or
following conditional event Stage changed, which cap-
tures a change of stage due to an exacerbation. Sig-
nal events are used for broadcast communication and,
in the depicted process, they represent the interaction
between the two sub-processes Management of Stable
COPD and Management of COPD Exacerbations. Throw-
ing signal events are characterized by a filled triangle
marker, whereas catching signal events have a unfilled
maker of the same sort. Whenever signal event Re-
schedule is caught, sub-process Management of Stable
COPD is interrupted and restarted, according to the pe-
riodicity defined for the newly assessed stage. The end
of the described macro-process is reached once all in-
terventions for COPD management and exacerbations
are concluded.




























Fig. 5 BPMN diagram outlining the three main steps of the
studied COPD care pathway, each one represented as a sub-
process. Sub-process COPD Diagnosis and Assessment is al-
ways executed first, followed by Management of Stable COPD,
which is performed periodically, according to the assessed
stage. Ordinary examinations can be rescheduled whenever
the COPD stage assigned to the patient changes due to the
progressive worsening of the disease or following an exacerba-
tion episode, the latter handled by sub-process Management
of COPD Exacerbations.
Figures Fig. 6, 7, and 8 show the BPMN diagrams
representing the structure of the three introduced sub-
processes. The detailed discussion of the structure of
such sub-processes and of the related clinical activities
is reported in Appendix A. In these process diagrams,
different tasks types are used to denote decision tasks,
i.e., process activities incorporating decision-making,
which can be represented through a linked DMN de-
cision model, at different levels of detail. As described
in Section 2.3, we employ user tasks to denote activ-
ities that encompass human-decision making, whereas
business rule tasks are used to highlight partially auto-
mated decision-making [20].
All the other process activities are represented as
abstract tasks or sub-processes, that is, generic activi-
ties whose behavior is not further specified [14].
In the BPMN diagrams, the recording of data to
persistent databases is represented through data stores.
For readability reasons, we used data objects to show
only the exchange of information between different re-
sources, while omitting details related to data flowing
through activities executed by the same resource.
In particular, the presented processes need to com-
municate with the following information systems: The
primary care information system, represented by data
store PCU db, is the system used by general practi-
tioner to store patient data – This system is usually
shared among the practitioners that belong to the same
PCU; The hospital information system, represented by
data store Hospital db, stores different patient medical
records; Finally, the health district authority informa-
tion system, represented by data store HC district db
is mostly used to record data regarding vaccinations
and related campaigns. Nowadays, the three informa-
tion systems are only partially connected, since data
about drug prescriptions and examination scheduling
are shared between PCUs and hospitals, but most data
are still exchanged between professionals through re-
porting documents. The region of Veneto is currently
working on developing a unified electronic health record
that will allow practitioners, hospital personnel, health
district authorities, and pharmacies to access the same
data repositories.
4.3 Modeling clinical decisions with DMN
Process-related decisions have been modeled in detail
by using DMN diagrams and, sometimes, by specify-
ing more detailed decision logic. A few decision models
corresponding to the COPD diagnosis and assessment
process had already been introduced in [9]. In this para-
graph, we focus on describing the decision modeling for
the previously described management of COPD exac-
erbations process.
In the management of COPD exacerbations, a cru-
cial step is represented by the diagnosis and assess-
ment of an exacerbation, which is evaluated by com-
bining physical findings with the clinical history of the
patient [56, 66]. In general, clinical diagnosis is proba-
bly the most important example of complex, decision-
intensive medical task. Indeed, diagnosis encompasses
aspects of human decision-making that rely on medical
knowledge, professional experience, and sound sources
of clinical information. For this reason, modeling clin-
ical diagnosis by means of formal approaches can be-
come quite cumbersome, as it involves complex (tem-
poral) reasoning and uncertain and incomplete knowl-
edge [67]. Nevertheless, the representation of structure
of a decision and of its meaning is interesting for the
organization and can be realized by using DMN De-
cision Requirement Diagrams, which allow one to de-
scribe decision-making at quite a high level.
As an example, consider the DMN diagram repre-
senting the diagnosis of a COPD exacerbation, depicted
in Fig. 9. The diagnosis of an exacerbation relies on the
clinical presentation of the patient, who consults the
















































































































Standard spirometry can be carried out
in IPCUs whenever the facility is provided
with a spirometer. Otherwise the test
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Priority based on CAT,
smoke test results, and
on PBS results
Frequency
STAGE I: within 2 years
STAGE II: within 1 year
STAGE I: mMRC test at every
examination,
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Care pathway continues with ordinary management of COPD
Fig. 6 BPMN process diagram for COPD diagnosis and assessment. The main decision activities identified with the help of
experts are Case history and working diagnosis, which is a preliminary step of decision Diagnosis of COPD, and COPD staging.


















































































































































Indicator 9: Adherence to therapy
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Fig. 7 BPMN process diagram for the ordinary management of stable COPD.
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oximetry, ABG, Chest radiographs,
ECG, Whole blood count, purulent
sputum
The patient is hospitalized when:
- COPD symptoms are acute
- preponderance of sensory
disturbances
- acute exacerbation
- new cardiac arrhythmia































































Fig. 8 BPMN process diagram for the extraordinary management of COPD exacerbations.
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Fig. 9 Decision Requirement Diagram representing the main
decision Diagnosis of COPD Exacerbation, together with the
input data needed for making the decision, the used business
knowledge, and the sources responsible for the decision. The
decision is linked to task Diagnosis of exacerbation of Fig. 8.
general practitioner complaining of substantial symp-
tomatic and physiologic deterioration [23].
In the DRD of Fig. 9, Diagnosis of COPD Exacer-
bation is portrayed as the main decision, which ideally
responds to the question “Is the patient experiencing
an exacerbation of COPD?”. The decision is made by a
General Practitioner, represented as a knowledge source,
who is responsible for assessing the degree of symp-
tom worsening and for evaluating if the exacerbation
is life-threatening. Several clinical findings have to be
considered when assessing an exacerbation. During a
physical examination, Pulse oximetry is performed to
assess the need for supplementary oxygen therapy. Be-
sides, Hemodynamic stability, Use of accessory respiratory
muscles, and Response to treatment are evaluated. The
general practitioner must also consider the number of
previous exacerbation episodes and the Presence of co-
morbidities, which are combined with information about
COPD severity to predict the patient risk of exacer-
bations. COPD severity corresponds to the output of
sub-decision Evaluate Severity of COPD, which is based
on Spirometric assessment. Results of previously admin-
istered CAT, Spirometric assessment, and History of ex-
acerbations are retrieved from the PCU db, depicted as
knowledge source. Probability of comorbidities is a busi-
ness knowledge model that describes the kind of comor-
bidities that are commonly found during an exacerba-
tion and the probability of finding more of them. Busi-
ness knowledge models describe a reusable fragment of
decision logic or know-how, which can be retrieved by
guidelines or by local organizational knowledge. In the
Probability of	Comorbidities










Fig. 10 Boxed literal expression, written in plain English,
and representing the decision logic of the Probability of Co-
morbidities business knowledge model.
presented context, the knowledge is based on data col-
lected in the region, since the probability of comorbidi-
ties changes according to the distribution of the pop-
ulation in the territory. Similarly, business knowledge
model Assess risk of exacerbations encloses the knowl-
edge required for assessing exacerbation risk, based on
the combination of COPD severity, symptomatic assess-
ment and history of previous exacerbations [23].
The diagram of Fig. 9 is linked to the user task Di-
agnosis of exacerbation of the process shown in Fig. 8.
The result of the decision is used by gateway Is exacer-
bation life threatening to determine if the patient must
be treated in outpatient settings or hospitalized.
The DRD introduced in Fig. 9 encompasses both
human decision-making and partially automated deci-
sions, the latter ones reviewed and validated by the gen-
eral practitioner. For the main decision Diagnosis of Ex-
acerbation we decided not to specify decision logic, as
the presented DRD suffices in explaining the expected
structure and input data needed to make this human
decision. However, a few elements in the considered dia-
gram have a decision logic specified at different levels of
abstraction, by using the various expressions provided
by the DMN standard [20]. In detail, decision logic for
business knowledge model Probability of comorbidities
is represented by a boxed a literal expression, shown in
Fig. 10, written as plain English text and, thus, not suit-
able for automation. Conversely, sub-decision Evaluate
Severity of COPD is based on well-defined rules that de-
termine how the amount airflow limitation should be as-
sociated to a specific COPD stage. Hence, decision logic
can be easily represented by means of a decision table
that relates spirometric values FEV1 and FEV1/FVC to
the corresponding COPD stage. Fig. 11 shows the deci-
sion logic of decision Evaluate Severity of COPD, which
invokes decision table Evaluate Severity of COPD Table,
passing Spirometric assessment.FEV1 as FEV1 parame-
ter and Spirometric assessment.FEV1/FVC as FEV1/FVC
parameter. Decision Evaluate COPD Severity, invokes
the corresponding decision table. The presented table
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has been verified with Signavio and, as expected, it is
not complete as no rule exist for (≤ 70%, any). How-
ever, this omission was intentional, since this latter case












1 <	70	% >=	80	% “Mild”
2 <	70	% [50%..80%) “Moderate”
3 <	70	% <	50% “Severe”
Fig. 11 Decision table representing the decision logic for de-
cision Evaluate severity of COPD, based on spirometric data.
Finally, as an example of formal expression allowed
in DMN, consider the decision logic for business knowl-
edge model Assess risk of exacerbations, represented in
Fig. 12 through a boxed FEEL expression which de-
scribes how an output value is derived from its in-
put values. The presented formal expression is used
for combined COPD assessment in order to understand
which is the impact of COPD on an individual pa-
tient, in terms of future exacerbations, based on cur-
rent symptoms, spirometric assessment, and exacerba-
tion history [23]. Patients are classified into 4 main cat-
egories, which summarize the risk of exacerbations and
expected health status. For instance, a patient with a
CAT score of 16, assessed with “Moderate” COPD, and
a history of 3 exacerbations within the last 12 months




ExacerbationsPerYear	IN ( [0..1] ) and	CAT	<=	10	
then Risk	of	Exacerbations =	“LOW,	LESS	SYMPTOMS”
else	if	COPD	Severity	IN (“Mild”,	“Moderate”)	or	
ExacerbationsPerYear	IN ( [0..1] ) and	CAT	>=	10	
then Risk	of	Exacerbations =	“LOW,	MORE	SYMPTOMS”
else	if	COPD	Severity	=	“Severe”	or	
ExacerbationsPerYear	IN ( [0..1] ) and	CAT	<=	10	
then Risk	of	Exacerbations =	“HIGH,	LESS	SYMPTOMS”
else Risk	of	Exacerbations =	“HIGH,	MORE	SYMPTOMS”
Fig. 12 Decision Logic for the Assess risk of exacerbations
business knowledge model, adapted from guidelines on com-
bined COPD assessment [23].
4.4 Dealing with information and process indicators
The modeling of the described COPD processes and
decisions underlined the strong connection that exists
between processes and related clinical and organiza-
tional information, throughout all the design phase.
On the one hand, data needed for process and deci-
sion execution must be identified during process de-
sign, to define which is the information needed during
process enactment. On the other hand, new informa-
tional value generated during process simulation and
execution must be properly managed and used for re-
engineering as-is processes and decisions. In the man-
agement of chronic diseases, most clinical knowledge
and conformance data stem from standard guidelines,
whereas operational data are retrieved from process
logs or health information systems [68]. However, health
information systems are usually meant to serve multiple
and disparate care processes and, thus, data availabil-
ity, standardization, and maintainability may become a
complex issue.
In the studied context, a first step towards the iden-
tification of a minimum set of data that are relevant for
process execution and audit is represented by the defi-
nition of process indicators, used to assess the quality of
the provided care from different viewpoints and levels
of abstraction.
The definition of indicators is part of the care pro-
cess specification and is done by a “focus group” of clin-
ical experts, who identify clinical, organizational, and
social criteria for evaluating process outcomes [69]. In-
dicators are used to validate the structure of the pro-
cess and to evaluate the organization potential in terms
of resource distribution and consumption. In addition,
they are useful to estimate process compliance with re-
spect to both clinical and organizational outcomes, and
cost sustainability.
4.4.1 Local KPIs
An example of local KPI related to process metrics is
the average total cost spent by the Regional Health-
care System for treating COPD patients assessed with
Stage 3. Local KPIs allow one to quantify the proba-
bility that a process execution path is preferred over
another, within the context of a data-based process
gateway. For instance, the percentage of smoking pa-
tients determines how many times the care providers
involved in the process of COPD treatment have to
deal with smoke cessation. In the region of Veneto, it
has been estimated that the probability of contracting
COPD for smokers 25% higher than for non-smoking
patients, and can increase up to 30% in patients that
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smoke more than 30 cigarettes per day. In the process
of Fig. 6, this probability value influences the execution
of all tasks that concern the administration of smoking
questionnaires, as Mondor and Fagerstörm tests can be
skipped if the patient is not a smoker. Local KPIs can
also be derived and evaluated with process simulation
techniques, as explained in Section 4.5.
4.4.2 Global KPIs
The indicators defined by the Regional Healthcare Sys-
tem of Veneto are global KPIs used to give a high level
estimate of the impact of care standardization in terms
of costs, patients involvement, and medical personnel
competence. Such indicators have been highlighted as
text annotations in the process diagrams of Section 4.2.
Indicators were provided by clinicians and they have
been defined by the Regional board. Our goal was not
to define them directly, but rather to show where in the
process they are calculated.
For instance, Indicator 5: Performed Vaccinations is
defined to quantify the number of performed influenza
vaccinations, in order to assess the quality of secondary
prevention of COPD. It is defined as the proportion be-
tween patients diagnosed with COPD (i.e., ICD-9-CM
491.2x e 496.x) aged at least 40, and having received
a vaccination against influenza in the last 12 months
and the total of COPD patients aged at least 40. This
indicator is associated to task Verify administered vacci-
nations of the process shown in Fig. 7 and experts ex-
pect the value of this indicator to remain greater than
the 40% of all the patients diagnosed with COPD (and
quantified by Indicator 2A). Any value lower than the
expected threshold should be considered an index of
poor process performance, to be further investigated
by considering re-engineering. With process manage-
ment tools, Indicator 5 can be calculated by counting
how many times the process branch labeled with YES
is followed after each exclusive gateway Vaccination ad-
ministrated?. As for data requirements, this indicator
suggests that the following data need to be collected
during the care process: A patient identifying code, the
diagnosis of COPD registered according to the ICD-
9-CM coding systems, the influenza vaccination, and
the date of the vaccination. As for the global scope of
the indicator, data about the performed vaccinations
gathered during the management of stable COPD in
Veneto, are combined with data collected at a national
level to evaluate the efficacy of routine vaccination pro-
grams. In the years 2002-2009, 32% of Italian popula-
tion received vaccination against influenza, whereas in
the years 2010-2016 the same value dropped to 18%.
Among patients with COPD, around 75% of them re-
ceived a vaccination against influenza in the same time-
span. This drop in the number of vaccinations, high-
lighted by Indicator 5, can be explained by the recent
spread of several anti-vaccination movements that de-
veloped in the considered territory in the last years. As
a consequence, new vaccination programs were intro-
duced, patients were actively informed about the risks
of non-vaccination, and a service for delivering vacci-
nations at home was provided. This latter intervention
was directed not only to COPD patients, but to all
those considered at risk by the National Healthcare Sys-
tem, whence the global scope.
As a further example, here we report the definition
of Indicator 7, translated in English from Regional doc-
uments related to the care pathway.
Definition 1 (Indicator 7 - Appropriateness of
therapy (Fig. 7))
Description: Appropriate therapeutic use of only bron-
chodilators in people diagnosed with COPD in stage 2.
Numerator: Number of people diagnosed with COPD
(i.e., ICD9-CM 491.2x and 496.x) and assessed with
stage 2 and receiving only bronchodilator therapy.
Denominator: Totality of patients diagnosed with COPD
(i.e., ICD9-CM 491.2x dan 496.x) and assessed with
stage 2.
Needed Data: Patient ID, prescription data regarding
short and long term bronchodilators (prescription code
ATC R03).
The remaining indicators defined within the pro-
cesses can be used as Indicator 5 and Indicator 7 to de-
fine (clinical) data requirements and measure clinical
and organizational outcomes.
As for relationships between local and global KPIs
and HQCIs in the specific case of COPD care, we men-
tion here the quality indicator PQI 05 - Chronic ob-
structive pulmonary disease (COPD) or asthma in older
adults admission rate [70], which is closely related to the
definition of COPD patients, adopted by the Veneto
Region and related to Indicator 1 – prevalence of pa-
tients with suspected COPD. Indeed, the identification
of patients with COPD is based on the following criteria
from hospital and drug prescriptions:
– admissions with a principal/secondary diagnosis of
COPD (codes ICD-9-CM: 490-492, 494, 496), ages
45 years and older, or
– sound and continuous drug prescriptions related to
respiratory treatments (the detailed specification is
done with respect to the overall duration of the ther-
apy in the last two years, the number of prescrip-
tions, and the ATC therapeutic class of drugs).
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A further example of HQCI that could rely on the
modeled COPD process is the Indicator NQMC:010510
defined as Use of spirometry testing in the assessment
and diagnosis of COPD: percentage of members 40 years
of age and older with a new diagnosis of COPD or
newly active COPD, who received appropriate spirom-
etry testing to confirm the diagnosis [71]. Indeed, such
indicator is enforced to be 100% for patients treated
according to the given pathways (without considering
some small differences with respect to the age of pa-
tients), as all patients undergo spirometry either in PCUs
or at the hospital.
4.5 Simulation of COPD processes
In the application of the proposed methodology, we
used simulation for validating the behavior of the mod-
eled COPD processes by spotting pitfalls related to er-
roneous control flow. Then, we evaluated the perfor-
mance of the processes based on current data collected
from the Regional Healthcare System, and we studied
the behavior of the processes when dealing with hypo-
thetical scenarios. The latter ones have been defined
according to the indications of experts, who were inter-
ested in gathering insights regarding both the quality
of the interactions between process resources and the
performance in case of increased amount of patients in
severe conditions.
We exploited the simulation functionalities provided
by the Signavio Process Editor [17], which allows one
to directly open the process model in the simulation en-
vironment, without the need for further configuration.
Decision logic has been simulated with the Camunda
DMN Simulator [72], which allows one to verify the
output of a decision table, given custom input values.
Signavio supports three kinds of simulation of syn-
tactically sound BPMN processes (verification of the
syntax is done by the tool prior to simulation), namely
step-by-step, one-case, and multiple case simulation.
Step-by-step simulation is guided by the modeler, who
chooses which process flows are enabled, and it is mainly
used for verifying that the process captures all the pos-
sible desired execution behaviors. This is fine for rep-
resenting and observing the process flow and, there-
fore, it can be used when interacting with clinicians for
improving common understanding. One-case simulation
allows one to interactively reproduce the execution of a
single process instance, according to specific conditions
defined on process execution. Conversely, multiple-case
simulation supports the run of multiple instances of the
same process model, thus allowing one to aggregate re-
sults and analyze the overall workload of the process.
In all circumstances, Signavio allows flow-related tokens
to be graphically visualized, so that partial results can
be visually monitored by process modelers and stake-
holders.
The simulation tool requires the following informa-
tion in input:
1. the probability associated to each outcome of an ex-
clusive gateway (e.g., the proportion of COPD pa-
tients in Stage 3 for gateway Stage 3? in Fig. 6);
2. the fixed costs associated with each activity (e.g.,
spirometry performed in hospital costs around 25e);
3. the probability distribution that describes the dura-
tion for each activity (e.g., arterial blood gas anal-
ysis lasts 10 minutes, on average);
4. the hourly cost of each resource and the correspond-
ing working schedule.
Data regarding the costs and duration of examina-
tions have been collected by regional hospitals, by an-
alyzing scheduled events and medical reports. On the
contrary, the number of primary and hospital care re-
sources involved in the management of COPD is man-
aged directly by the Regional Healthcare System. Ac-
cording to regional data and experts’ knowledge, 185.000
patients are diagnosed every year in the Veneto region.
To obtain a reliable estimate of the amount of time
that each resource devotes to COPD care, we consid-
ered that COPD patients in Veneto correspond to the
7,9% of the overall regional population. Accordingly,
we assumed that the same proportion of patients is as-
signed to each practitioner, as in Italy each general doc-
tor is responsible for the same amount of patients. Of
course, we had to take territorial variance into account,
as the percentage of ill people increases up to 11,8% in
polluted areas. The same strategy has been adopted for
estimating the time that pulmonary specialists work-
ing in hospitals dedicate to COPD patients. Thus, we
considered having 3000 pulmonary specialists, working
15000 hours per week with COPD patients, and 3500
general practitioners, working 58000 hours per week
with COPD patients (i.e., on average 1 hour and 20
minutes of work for each general practitioners).
We created multiple simulation scenarios, starting
from those that reproduce current reality to interest-
ing what-if scenarios, suggested by experts. More par-
ticularly, we discuss here some simulations related to
processes COPD Diagnosis and Assessment and Man-
agement of COPD Exacerbations, considering different
aspects as (i) the proportion of spirometry test executed
in PCUs with respect to those executed in hospitals and
(ii) the increase in the number of patients diagnosed
with COPD during winter, for process COPD Diagno-
sis and Assessment, while focusing on (iii) longer hospi-
talization following exacerbations episodes for process
Management of COPD Exacerbations.
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4.5.1 Simulating process COPD Diagnosis and
Assessment
The first multiple case simulation focuses on the overall
yearly cost of the process, depending whether spirome-
try tests are executed either in hospitals or in PCUs. To
perform such simulation, we changed the proportion of
patients following different paths according to gateway
Spirometry prescription or direct request? in Fig. 6, which
specifies whether the spirometry has to be done at the
hospital or by PCUs. In Fig. 13, the difference between
the costs associated to the performance of spirometry
are shown. As discussed in [9], spirometry should be
preferably performed in PCUs, as the costs of hospital
spirometers is higher and waiting lists should be taken
into account. Indeed, spirometry tests in PCUs are ad-
ministered through cheaper devices, while in hospitals
spirometry tests are done with more expensive devices,
that should be reserved for severe respiratory compli-
cations.
the corresponding value in the simulation highlights a bottleneck regarding general practitioners 
(Figure 6). 
 
Figure 6: Bottleneck in the BPCO diagnosis process during winter months. 
 
Simple spirometry can be executed by the general practitioner or in a hospital: this choice has a 



























Percentage of spirometry tests performed in hospital or by the general 
practitioner
COPD Diagnosis costs
Figure 7: COPD diagnosis costs depending on the execution of spirometry in hospital or by the general 
practitioner. 






Yearly costs of simple spirometry in hospital and PCU
Fig. 13 Costs of the process COPD Diagnosis and Assess-
ment based on changing proportions of spirometry examina-
tions carried out in PCUs or in hospital.
A second simulation deals with the non-homogeneous
distribution of COPD diagnoses during the year. In-
deed, conditions of patients tend to worsen due to the
cold weather and evidence suggests that in Veneto there
are 15% more cases of COPD diagnosed in winter than
on average during the year. According to these obser-
vations coming from regional data and experts’ knowl-
edge, physicians and healthcare stakeholders were inter-
ested in having an estimate of resources and costs dur-
ing such season. Thus, we simulated the process COPD
Diagnosis and Assessment for 120 days, corresponding
to the average period of cold weather, considering that
68800 patients are diagnosed in the given period. Such
amount of patients is derived by considering that there
are 5 working days per week (i.e., 86 days in 120 day
frame), and 800 patients are managed every working
day, thus considering an increase of about 15% with
















































































































Standard spirometry can be carried out
in IPCUs whenever the facility is provided
with a spirometer. Otherwise the test
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STAGE I: mMRC test at every
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Total cycle time Total cycle time
Resource Consumption Resource Consumption
Bottlenecks Bottlenecks
€ 104,164.05 € 89,984.15
4856d 13:48h5800d 18:40h
108d 12:30h 93d 12:50h
General Pract… _ _ _
Fig. 14 Simulation results shown in Signavio for scenario
Winter, run on 68800 instances ov r 120 days. The tool high-
lights a bottleneck corresponding to the general practitioner,
who is responsible for diagnosing COPD.
Th simulation interface, shown in Fig. 14, suggests
a bottleneck in correspondence of the general practi-
tioner, who is ove loaded with the first diagnostic as-
sessment. Fig. 14 depicts in the blue bar at the right of
activity Case history and working diagnosis the value of
67300 (lower than the total number of patients – 68800),
which is the number of patients who can be manag d
in the given period according to the actual number of
available physicians. To complete the results of simula-
tion and to allow the comparison of diffe ent scenarios,
the part on the right of Fig. 14 reports quantitative
results from the simulation of the winter scenario and
from the simulation of the standard one. In particu-
lar, the report depicts costs, total cycle time, which is
th overall amount of durations needed t complete all
the process instances, and resource consumption, that
is the amount of time resources need to execute the pro-
cess. All these results can be expanded and visualized
in detail. For instance, when clicking on the highlighted
red box related to Bottlenecks in Fig. 14, we are able
to see that the workload for each general practitioner i
estimated to be around 184 days full-time, which is an
excessive amount compared to the considered working
schedule for 120 days.
4.5.2 Simulating process Management of COPD
Exacerbations
Simulation results of process Management of COPD
Exacerbations, depicted in Fig. 8, obtained for different
lengths of hospitalization, are outlined in Fig. 15. Costs
shown in the histogram are calculated by summing the
fixed costs of hospitalization with the costs associated
to the resources. In detail, we simulated the case of hav-
ing 72000 patients experiencing COPD exacerbation
and considered that the 34% of them is hospitalized.
Moreover, we considered different average hospitaliza-
tion lengths, ranging from 3 to 20 days. As expected,
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Average hospitalization length (days)






Fig. 15 Simulation results of process Management of COPD
Exacerbations considering different hospitalization lengths,
run on 72000 instances over 100 days, with 23800 patients
hospitalized.
the costs of the process increases drastically whenever
patients are hospitalized for a longer time. The distribu-
tion of the total cost of process Management of COPD
Exacerbations considering the most relevant tasks for
expense calculation is shown in the pie chart of Fig. 16.
The depicted results correspond to the execution of the













Fig. 16 Distribution of the total cost of executing process
Management of COPD Exacerbations, considering a hospi-
talization length of 15 days.
5 Related Work
In this section, we discuss related work by focusing on
different approaches for healthcare process design. We
begin with presenting work proposed by the community
of BPM and information systems. Then, we focus on
research efforts conducted in the field of medical infor-
matics, oriented to the development of CIGs systems.
Finally, we discuss and compare our contribution with
the introduced approaches.
5.1 Healthcare process modeling in BPM
Process management approaches have been employed
in healthcare to support the modeling and enactment
of organizational interdisciplinary processes [5]. How-
ever, applications of process modeling approaches in
healthcare are still modest, despite the suitability of
BPM techniques for representing complex and multi-
disciplinary organizational procedures. In addition, ex-
isting approaches tend to target specific clinical do-
mains rather than proposing general methodologies, as
exhaustively surveyed in [2].
Healthcare is considered a challenging domain for
BPM approaches, as flexibility is often required and
processes heavily depend on both information and knowl-
edge [1,5]. According to [35], a knowledge-intensive pro-
cess is a workflow whose conduct and execution are
heavily dependent on knowledge workers performing
various interconnected and knowledge-intensive decision-
making tasks, whose management and execution re-
quires specific support. The role of human knowledge
is considered central in such processes and, due to the
variability in their structure, they cannot be directly
mapped to business process diagrams.
However, organizational aspects of knowledge-intensive
processes can be captured by BPM techniques [2, 5],
whereas clinical or medical treatment processes can suit-
ably handled by case management or artifact-based ap-
proaches [24, 73–75]. For instance, the ADEPT frame-
work [74] allows one to revise running process instances
and schemata in order to support the management of
clinical guidelines. Among the interesting features of
ADEPT, modularity, ease of use and management of
temporal aspects stand out. In the context of case man-
agement, a clinical pathway for living donor liver trans-
plantation was firstly modeled using BPMN in [75].
Then, in order to facilitate transferability of the mod-
eled pathway to other hospitals and to include flexi-
bility caused by differences in treatments due to local
policies, the processes have been modeled by using the
OMG standard Case Management Model and Notation
(CMMN) [24]. This standard can be used to model spe-
cific cases, together with the data that drive their ex-
ecution, in order to simulate the decisions taken by a
knowledge worker during process run-time.
However, traditional BPM approaches are activity-
centric, that is, they focus on representing the pro-
cess control flow, by supporting structured and repeti-
tive organizational processes. As for BPMN-based ap-
proaches, BPMN is used for modeling surgical pathol-
ogy processes in [6]. According to the authors, the no-
tation was chosen because it is widely accepted and
recognized in industry, due to the easiness provided for
the design of simple or high level processes. Indeed, they
advocate that the obtained models have be as simple,
transparent and understandable by care providers.
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Most research proposals focus on extending the core
of the BPMN notation to improve its expressiveness
with respect to the design of healthcare processes, often
introducing new elements that are tailored for modeling
specific clinical circumstances. In [76], the authors pro-
pose a conservative extension of BPMN for the health-
care domain, with the aim of incorporating role infor-
mation and facilitate the assignment of tasks to per-
forming resources. A major extension to BPMN, pro-
posed to systematically support the design of clinical
pathways, is developed in [77]. This extension, named
BPMN4CP, incorporates concepts retrieved from the
context of clinical pathways, with the aim of enhancing
evidence-based decision activities related to the con-
sidered domain. New tasks types are added to model
medical diagnosis and therapies, whilst different data
objects types are used for representing documents re-
lated to both medical and administrative procedures.
Conceptual modeling of care pathways is addressed
under different viewpoints in [78] and [79]. Specifically,
in [78] a novel methodology for connecting processes
and data belonging to a healthcare information sys-
tem is proposed, based on the concept of task view,
which represents the information that can be accessed
by a process task and that is relevant for its execution.
In [79], a data-aware representation of BPMN processes
is presented as a means to support clinicians working
in ICU to understand their responsibilities in the care
process, how therapies are temporally constrained and
which are the critical decisions that affect the quality
of the provided care.
The processes design in [79], have been further re-
fined and used in [80] as a blueprint for guiding the de-
velopment of a rule-based decision-support system for
antibiotic stewardship.
Finally, in [81] two clinical pathways for colon and
rectum carcinoma are designed as part of a pilot project,
with the aim of evaluating the benefits of using BPMN
for modeling structured medical procedures.
A general methodology for the design of medical
processes was recently presented in [82]. The authors
present an approach based on three main phases for
healthcare process modeling, starting from context anal-
ysis and addressing the design of conceptual and logical
process models. UML Activity Diagrams are chosen to
represent processes, in order to ease integration with
other UML diagrams, suitable for representing other
aspects of the clinical domain. Despite the motivations
described in [82] are similar to those addressed in this
paper, the two methodologies have different focuses.
In [82] the integration of medical processes and health
information systems plays a central role, whereas the
modeling and management of decisions is not specifi-
cally addresses. Moreover, authors provide a mapping
towards logical formalisms, while we focused mostly
on conceptual design, yet completing it with organiza-
tional analysis based on KPIs and process simulation.
In general, all the presented approaches are directed
to expert modelers and aim at improving understanding
and, in some cases, standardization of care procedures
under an organizational standpoint.
However, as processes are becoming more and more
decision-intensive, the need for a more appropriate lan-
guage to support the modeling of process-related de-
cision has recently been recognized within the BPM
community. In healthcare, user decisions and unpre-
dictable events contribute to the continuous generation
of new clinical knowledge, thus making the structure
of the processes less rigid. The previously introduced
BPMN-based approaches, do not explicitly deal with
the design of process-related decisions, as these either
tend to remain hidden within other process elements
or are managed by dedicated decision support systems.
In general, clinical decision support is often directed
to medical personnel, whereas decision management is
useful to serve organizational purposes.
DMN has been proposed to model different aspects
of decision-making and to complement BPMN to this
end. The recently proposed notation allows one to model
decision requirements and decision logic following the
well-known “separation of concerns” paradigm [21]. This
latter principle allows designers to keep process and de-
cision modeling separate, which is desirable to reduce
complexity and improve model maintainability and scal-
ability [29]. DMN has been used for decision-making de-
sign in the context of collaborative networks in [40]. An
approach to derive DMN decision models from BPMN
process models is discussed in [83]. Upon having iden-
tified important decision steps in the process, decision
logic is extracted from process logs, in the form of deci-
sion tables, and a compound DMN model is constructed
with the aim of re-adapting the process diagram to
fit the modeled decision logic. A logic-based formaliza-
tion of DMN decision tables has recently been provided
in [84], in order to unambiguously define a semantics for
such constructs and introduce several analysis tasks, fo-
cused on correctness checking. However, at the best of
our knowledge, DMN has not yet been applied for mod-
eling clinical decisions, despite the suitability of decision
requirement diagrams for the design and sharing of hu-
man decision-making. Indeed, decisions in healthcare
are complex, shared among different professionals, and
often rely on medical evidence and expertise. Despite
the formalization of these aspects is quite complex, ex-
planatory decision requirements diagrams can be used
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for compliance, standardization, and training and edu-
cational purposes.
Finally, business process re-engineering (BPR) re-
quires a clear understanding and a radical re-design of
organizational procedures, in order to overcome criti-
cal steps and to improve process performance, flexibil-
ity and adaptability to change. Most re-engineering ap-
proaches focus on re-thinking the process control flow,
in order to allow parallel execution of activities and
resource re-allocation with the aim of reducing exe-
cution times and costs. In this scenario, data and de-
cisions are often managed and re-engineered indepen-
dently and only information related to process metrics
is employed for this scope. Examples of canonical ap-
plications of process and knowledge re-engineering in
healthcare are discussed in [7, 85, 86]. In detail, in [7]
a framework based on event driven process chains, the
entity-relationship model, and discrete event simulation
is introduced in order to define and analyze the current
state of a surgical ward and design an improved sys-
tem. A more general study addressing the identification
of those business process re-engineering principles that
can improve the application of E-Health technologies
within a healthcare environment is conducted in [85].
5.2 Clinical and healthcare process modeling: Clinical
Interpretable Guideline approaches
Despite the complexity of medical and clinical processes,
the community of medical informatics has been actively
investigating and developing systems for the modeling
and management of clinical practice guidelines [2].
Computer-interpretable guidelines (CIGs) are for-
malizations of clinical practice guidelines aimed at fos-
tering the development of guideline-based decision sup-
port systems [87]. In general, the implementation of
guideline-based support systems requires timely data
sharing, to ensure communication between care provi-
ders, data completeness, and correct formalization of
guideline rules and statements [88]. In addition, proper
clinical knowledge and decision management features
must be provided for dealing with knowledge-intensive
care processes.
According to [89], the following areas of develop-
ment must be considered when modeling clinical guide-
lines: (i) modeling and representation, (ii) acquisition,
(iii) verification and testing, and (iv) execution and
monitoring. The most relevant CIGs formalisms are ex-
haustively reviewed in [87]. Here, we focus on discussing
workflow-based approaches and task-network models,
as the structure of the latter ones can be compared to
the concept of process control flow.
Workflow and process modeling techniques have been
applied for specifying, designing and implementing pro-
cedural aspects of clinical guidelines. One of the most
complete projects addressing the integration of clinical
guidelines into organizational workflows is the GUIDE
project, developed within the Careflow framework [90].
GUIDE is a multi-level architecture designed to inte-
grate a formalized model of the medical knowledge re-
trieved from clinical guidelines with workflow manage-
ment systems. The presented approach is based on com-
putational formalisms that facilitate the work of health-
care stakeholders by suggesting them the medical task
to execute and the resources to allocate.
In [50], the authors introduce a temporal model for
fostering the conceptual design of clinical workflows
for stroke prevention and management, by addressing
activity duration, delays, periodic and absolute con-
straints and inter-activity constraints.
As for CIGs formalisms, several languages for clin-
ical guideline modeling have been proposed, such as
GLIF [91], Asbru [92], PROforma [93], and SAGE [94].
The Guideline Interchange Format (GLIF) was pro-
posed to ease guideline sharing [91]. The core language
includes several ontological entities that allow the rep-
resentation of guidelines as multi-step flowcharts that
support branching logic. The current core, GLIF3, sup-
ports the modeling of guidelines at different abstrac-
tion levels, namely conceptual, computable, and imple-
mentable. An interesting aspect of GLIF3 is the hi-
erarchical modeling of decisions, which distinguishes
between automated decision steps and those that are
made by a health worker. Asbru [92] enables design-
ers to represent clinical guidelines, by considering con-
tinuous prescribed actions, and by supporting the par-
allel, in sequence, or ordered execution of care plans.
Sub-plans and their outcomes can also be specified.
PROforma [93] allows one to represent guidelines as
directed graphs of tasks, which can be either plans, de-
cisions, actions, and enquiries. Scheduling and temporal
constraints define task ordering, and task execution is
based on the triggering of pre-/post-conditions. Finally,
SAGE [94] builds upon previously introduced work [91–
93] and incorporates workflow representation, informa-
tion and terminology standards, and control flow stan-
dards. Likewise GUIDE [90], it fosters the definition
of an organizational model, with resources and roles.
Such model and the guideline model are kept separate,
to ease the adaptation of the guideline to local organi-
zational realities.
A recent architectural framework for promoting the
design, implementation, and evaluation of continuous
guideline-based decision support is presented in [95]. A
decision support engine, called PICARD, interacts with
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a guideline knowledge library and a temporal reasoning
service in order to apply medical knowledge to patient
data during the execution of clinical tasks. This frame-
work provides alerts and recommendations at the point
of care to health workers, patients, and knowledge engi-
neers. In detail, patients treated in home-care settings
can connect via a mobile client application to obtain
personalized recommendations. Care providers such as
physicians or nurses receive alerts, or therapy recom-
mendations based on telemedicine data. Knowledge en-
gineers can perform simulations on different guideline-
related scenarios. In addition, the architecture allows
accesses for the retrieval of procedural knowledge, usu-
ally expressed in terms of workflows. Currently, PI-
CARD is the backbone for MobiGuide [96], an intel-
ligent decision-support system for patients affected by
chronic diseases. Briefly, patients are provided with sen-
sors, which collect real-time information that is inte-
grated with clinical history data and medical knowledge
in order for supporting better decision-making. Alerts
and personalized guideline-based recommendations are
sent to patients, through their mobile phones.
A further contribution from the MobiGuide project
is described in [97], where the authors consider different
strategies for integrating CIGs with business processes
(organizational workflows, in the authors’ terminology)
and propose the implementation of some use cases in
the domain of atrial fibrillation. Such implementation
is based on a loosely-coupled integration of CIG and BP
engines, mediated through the health record database
system. With respect to our proposal, which focuses on
methodological issues, in [97] the authors pay attention
to more implementation-related issues, with the use of
several healthcare-related standards as IHE, HL7, and
other XML-based general standards. From this point
of view, no attention is paid to consider the expres-
sivity of BPMN advanced constructs, as events, excep-
tions, complex gateways, and so on with respect to the
specification of care pathways. Moreover, no methodo-
logical issues are discussed with regard to the design
of care pathways. As for more implementation-oriented
issues, standards such as HL7 [98], ICD9-CM [99], or
SNOMED CT [100] can be used to encode knowledge
in DMN requirement diagrams. In addition, they could
be used as values for FEEL expressions, as FEEL sup-
ports several kinds of data structures and its seman-
tics draws inspiration from Java, JavaScript, XPath,
SQL, PMML, Lisp, and many others [20]. In particu-
lar, FEEL is thought to be toolindependent, executable,
and expressive enough to support all kinds of decision
logic.
Among the first studies that considered both medi-
cal records, workflows, and HL7 standard to deal with
the derivation of quality indicators, we mention here
[101], where authors underline that workflow aspects
must be considered and modeled to evaluate quality
indicators. Such kind of results may be considered as
a motivation of our methodological proposal as it con-
firms that process-related aspects need to be considered
together with clinical data.
Generally speaking, despite both CIGs and BPM
approaches aim to improve healthcare processes and
decision-making, a few crucial differences can be dis-
cerned. CIGs are meant to be used by clinicians and,
thus, they focus on clinical decision support and on the
development of solutions tailored for dealing with a spe-
cific clinical guideline, enacted in a well-defined context.
On the contrary, BPM approaches in healthcare aim to
foster standard-based tools for supporting broader or-
ganizational as well clinical aspects in healthcare, han-
dled by physicians, healthcare professionals, and IT and
organization experts.
5.3 Discussion
In this paper, we provide an agile design methodol-
ogy, based on the well-known OMG standards BPMN
and DMN, that addresses the integrated yet compli-
mentary design, implementation, and enactment of care
processes and related decisions, considering the view-
point of an expert modeler. The introduced step-wise
approach promotes the iterative and agile design of or-
ganizational aspects of care pathways, mainly by focus-
ing on the standardization of processes and decisions.
The methodology supports incremental refinements, as
the modeler can choose how and how many steps to ap-
ply, depending on the final objectives. Procedural, deci-
sional, and informational aspects of care pathways are
represented in an integrated and scalable format, thus
supporting the re-use of clinical data and knowledge for
process and decision re-engineering. To our knowledge,
this is the first time a structured approach based on the
joint use of BPMN and DMN has been applied to the
healthcare domain.
Compared to the discussed contributions belonging
to the BPM community, the methodological approach
introduced in this paper utilizes conceptual modeling
techniques for purposes that go beyond clinical process
documentation and information sharing. Indeed, sim-
ulation and indicator-based process analysis are dis-
cussed, and the role of information in process man-
agement is promoted to first citizen in the methodol-
ogy. The integration of standard process modeling tech-
niques with systematic decision and information design,
possibly used for re-engineering purposes, is a novelty
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of the introduced methodological framework. In addi-
tion, the methodology is presented at a quite high level,
thus allowing the integration of other approaches, suit-
able to meet specific requirements. For instance, having
used the OMG notations BPMN and DMN, facilitates
the integration of CMMN models, in case there is the
need to deal with more flexible clinical aspects. Simi-
larly, standard ontologies and terminologies can be in-
tegrated in the BPMN and DMN processes, for defining
domain-specific concepts.
Whereas traditional process management techniques
are suitable for representing organizational aspects and
procedural process knowledge, computer-interpretable
guidelines approaches aim to support and facilitate ap-
propriate decision-making at the point of care. Usu-
ally, the main goal of such systems is to provide di-
rect decision support to clinicians, by fostering clini-
cal knowledge representation. For this reason, CIGs are
suitable to capture complex knowledge-based aspects of
clinical and medical treatment processes. However, the
main drawback of CIGs approaches is their lack of stan-
dardization [2,87], which motivated the introduction of
workflow-based approaches for better modeling organi-
zational aspects [90,94]. Indeed, despite the abundance
of language proposals, no specific proposal emerges over
the others, and each approach focuses on a selected set
of modeling aspects.
The goal of the proposed methodology is to start
from a standard, modular, and extensible core, that al-
lows one to exploit existing standard tools for health-
care process modeling. The benefits of using standard
tools are manifold. First of all, process and decision
modeling are based on graphical and understandable
notations, that can be conservatively extended and in-
tegrated with other (standard) approaches to suit the
need for flexibility required in the healthcare domain.
For instance, new types of tasks can be created in con-
formance to the standard, as done in [77], and process
cases can be added to handle run-time variability [75].
Secondly, process exchange, deployment, and verifica-
tion are supported by several tools, which may already
be used by the administrative counterpart of healthcare
organizations. Besides, modelers are facilitated by the
existence of numerous control-flow, data, temporal, and
resource design patterns [38,39,54,102].
In general, BPMN is a powerful language for cap-
turing various procedural aspects, as it provides a wide
range of constructs suitable for advanced event and ex-
ception handling. Especially in the context of tempo-
ral constraints, researchers are actively proposing ap-
proaches for the verification of a process temporal prop-
erties and for the resolution of related violations. Moti-
vated by processes taken from the domain of emergency
medicine, in [48] the authors propose an approach for
representing and verifying temporal constraints. These
are expressed by extending a basic BPM modeling nota-
tion and suitable algorithms have been proposed to ver-
ify dynamic properties of temporally-enhanced business
processes. TNest is a structured and modular workflow
modeling language providing full support of temporal
constraint specification during process design, presented
in [8]. In particular, TNest allows one to define two
main kinds of temporal constraints, that is, activity du-
ration and relative constraints. Finally, in [52] tempo-
ral constraints in the context of modularized processes
are investigated. In this setting, the re-use of process
knowledge must be enabled and, thus, authors consider
the issue of representing the overall temporal behavior
of a sub-process. This way, temporally enhanced sub-
processes can be used within other processes, hiding the
internal temporal features of such subprocesses.
Yet, born to capture process control-flow, BPMN
does not fully support other perspectives, such as the
representation of domain knowledge and the integration
of complex, structured data [5, 103]. Despite research
efforts are devoted in this direction considering clinical
domains [10, 55, 74, 75] the expressiveness of CIGs re-
mains more suitable for dealing with complex clinical
aspects, especially when developing tools that require
clinical knowledge and data representation and the di-
rect involvement of physicians and patients [96].
6 Conclusions
In this paper, we introduced a methodological frame-
work for supporting the design, implementation and
enactment of decision-intensive healthcare process, by
exploiting advanced process design techniques and by
integrating them with proper decision modeling. We ad-
vocate that combining the advantages derived from the
design of process and decision models, each one stress-
ing on a different care perspective, increases the over-
all value that such a synergistic design approach can
bring to care pathways development. In addition, the
proposed methodology provides a preliminary classi-
fication of the kinds of data involved during the dif-
ferent phases of process development. Proper informa-
tion and knowledge management allows stakeholders
to better support iterative process design, execution,
and re-engineering, thus leading to more flexible and
information-aware care pathways.
The advantages brought by the proposed method-
ology for care pathways design have been compared to
those achieved by computer-interpretable guidelines for
clinical process modeling. We concluded that whereas
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CIGs are suitable to build for decision support sys-
tems directed to clinicians, the use of BPM approaches
fosters the definition of a standard-based core of care
pathways and their related information, able to address
crucial aspects of healthcare organizations. Given the
technological and market-related scenario discussed for
BPM in the Introduction, we could easily compare the
current situation for BPM systems and healthcare to
the situation of Database Management Systems (DBMSs)
and medicine in the late ’80s and in the early ’90s.
At that times, many research efforts were related to
how to use and extend such database methods and
tools to manage (even complex) clinical data. Now, it
is completely obvious that any software system man-
aging large amounts of clinical data must rely on the
design and realization of a suitable database managed
by a DBMS. Similarly, it is becoming evident that any
software system for the management of care pathways
will rely and will have to consider BPM methodolo-
gies and technologies. According to this observation,
our proposal may be considered as a first attempt to
highlight specific issues we have to consider when de-
signing decision-intensive care pathways.
For future work, we intend to further investigate
the relationships between processes and healthcare data
models, in order be able to detail relevant data at a suf-
ficient level of abstraction, suitable for implementation
and integration within existing healthcare systems.
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A Modeling COPD subprocesses
A.1 COPD Diagnosis and assessment
Diagnosis of COPD has to take into account a multiplicity of
signs and symptoms. A clinical diagnosis of COPD should be
considered in any patient who has dyspnea, chronic cough or
sputum production, and presents a history of exposure to risk
factors for the disease [23]. Among genetic disorders that must
be considered in a diagnosis of COPD, the best documented
is α1-antitrypsin deficiency, which leads to an increased pre-
disposition to obstructive pulmonary disease [104].
Spirometry is required by international clinical guidelines
to make a diagnosis of COPD [23, 56]. Practically, a spirom-
eter measures how quickly full lungs can be emptied and the
total volume of air expired. Spirometric measurements used
in a diagnosis of COPD include:
– Forced Vital Capacity (FVC), which is the maximum vol-
ume of air that can be exhaled during a forced maneuver.
– Forced Expired Volume in one second (FEV1), which is
volume expired in the first second of maximal expira-
tion, during a forced maneuver. This value measures how
quickly lungs can be emptied.
– FEV1/FVC, which is the ratio between the two previ-
ously calculated values. FEV1 is expressed as a percent-
age of the FVC and gives an indication of airflow limita-
tion, called Tiffenau index [23].
Spirometry results are evaluated by comparison with refer-
ence values calculated on healthy subjects and depending on
age, height, gender, and ethnicity.
Currently, the spirometric criterion used for diagnosing
COPD is a post-bronchodilator FEV1/FVC ratio below 0.7.
Bronchodilators are medications that increase the FEV1 or
change the other spirometric variables, by altering airway
smooth muscle tone. Performing spirometry after the admin-
istration of a short-acting inhaled bronchodilator helps to dif-
ferentiate between an acute or persistent obstructive defect
and minimizes outcome variability [23]. However, the afore-
mentioned threshold is age-dependent and can lead to a sig-
nificant degree of overdiagnosis in the elderly and of under-
diagnosis in younger patients. Besides, as multiple respira-
tory diseases present a FEV1/FVC ratio <0.70, differential
diagnoses must be considered in order to determine an ap-
propriate treatment [105]. Chest X-rays may be prescribed
to confirm a working diagnosis of COPD and questionnaires
such as the COPD Assessment Test (CAT) are administered
for assessing symptoms. Indeed, when used in conjunction
with spirometry results and demographic data, these tools
have proven to enhance diagnostic accuracy [58].
For grading COPD severity, spirometric classification re-
mains the preferred standard method [23]. Post-bronchodila-
tor lung function, expressed in terms of FEV1 and FEV1/FVC
ratio, is used to classify COPD patients into four levels of
Severity FEV1/FVC FEV1
Stage 1 (Mild) < 0.70 ≥ 80%
Stage 2 (Moderate) < 0.70 [50%, 80%)
Stage 3 (Severe) < 0.70 [30%, 50%)
Stage 4 (Very Severe) < 0.70 < 30%
Table 2 Levels of COPD severity, based on spirometric as-
sessment, taken from [23].
severity [23], summarized in Table 2. Patients showing a post-
bronchodilator Tiffenau index greater than 0.70 are not con-
sidered in COPD management, despite those who smoke or
have exposure to pollutants are considered at risk and may
be targeted by prevention programs.
The BPMN process corresponding to COPD diagnosis
and assessment, depicted in Fig. 6, consists of a main pool,
which stands for the Regional Healthcare System. This is par-
titioned into two lanes, one representing a Primary Care Unit
and, specifically, a General Practitioner, the other one repre-
senting a Pulmonologist working in a Regional Hospital.
Since one of the goals of the COPD process models is to
define the respective responsibilities of general practitioners
and pulmonary specialists, only these two roles have been rep-
resented explicitly. Indeed, practitioners and pulmonologists
have to supervise the performance of nurses, technicians and
auxiliary personnel who collaborate in the process.
The process begins when the patient consults the general
practitioner, typically after having experienced some sort of
respiratory discomfort, such as productive cough, acute chest
pain or breathlessness. Case history and working diagnosis is
the first decision activity encountered, modeled as a user task,
which represents the gathering of useful observations during
medical inspection that are analyzed in conjunction with the
patient clinical history and exposure to risk factors in order
to formulate a working diagnosis of COPD.
All the collected information regarding symptoms, smok-
ing habits and risk factors is recorded in the local PCU database.
The following exclusive gateway, COPD Suspected? di-
rects the flow towards the prescription of spirometry and
further examinations, if a diagnosis of COPD is considered,
or towards the process end event, otherwise. Spirometry (in
PCU)/Spirometry (in hospital) is indicated to support COPD
diagnosis, to assess the severity of airflow obstruction and,
in some cases, it can be used as a prognostic indicator. If
patients in primary care have direct access to spirometers,
a simple spirometry test is requested and performed by a
general practitioner directly within a primary care facility.
Otherwise patients need a prescription for the spirometry to
be performed in hospital.
Under an organization standpoint, the biggest difference
between the performance of a spirometry in PCU or in hospi-
tal is waiting time. Whereas in PCU spirometric assessment
can be executed during a routine examination, spirometers in
hospitals are used for assessing various respiratory problems
and patients are prioritized according to the severity of their
conditions.
Chest X-rays may also be carried out in hospital, if be-
lieved necessary to support the diagnostic process. Spirome-
try allows measuring FEV1, FVC and the ratio between such
values.The physician must Read and record spirometry results
received with the corresponding reports, and compare them
with reference values for age, weight, height, gender, and eth-
nicity. If airflow obstruction is detected, the practitioner must
Prescribe post-bronchodilator spirometry (PBS) to confirm the
diagnosis of COPD and to measure the degree of airflow
obstruction and its reversibility. Once the patient has been
informed and advised about the conduct of the test, Post-
bronchodilator spirometry is performed by a pulmonologist in
hospital. Subsequently, the pulmonologist must Write PBS re-
port, containing the diagnostic statement and the spirometric
results. This is sent to the general practitioner, who must
confirm the diagnosis of COPD and record the patient data
in the primary care unit database, following the ICD-9-CM
coding rules [106]. The general practitioner can also Prescribe
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pharmacological treatment, whenever considered necessary to
relieve the patient from symptoms. Then, the COPD Assess-
ment Test (CAT) is administered to gather information about
the impact of COPD on the patient’s quality of life and to
measure general health status impairment. If the patient is
a smoker, additional tests, i.e., Mondor and Fagerstörm, are
administered to reveal addiction to tobacco consumption and
nicotine [107].
Once the test-based assessment is concluded, the physi-
cian needs to Inform the patient about his/her clinical con-
dition and can suggest a detoxing treatment in specialized
facilities for smoking cessation. Then, the patient undergoes
a Pulmonary examination in hospital, which results in COPD
staging, based on the outcomes of the previously executed
spirometric assessment. The staging report is authored by the
pulmonologist and must contain the assessed COPD stage,
the value of the Tiffenau index, an indication for medical ex-
aminations and future re-evaluations, and therapeutic advice.
The general practitioner receiving the report, must verify that
the assessed stage is correct before proceeding with COPD
stage recording as he/she is responsible for signaling possible
incongruities. Indeed, the classification of COPD patients is a
crucial decision as the planning of the future inspections, both
in terms of the kind of medical analyses required and their
frequency, depends on the severity of the assessed grade. If
the patient is in Stage 3, a pulmonary specialist in hospital is
put in charge of monitoring the patient. In this case, the pul-
monologist must Prescribe Pharmacological Therapy, Schedule
pulmonary examination, Schedule post-bronchodilator spirom-
etry, and Schedule 6-Minute Walk Test (6MWT) to monitor
the disease, and to evaluate the patient’s functional exercise
capacity. Conversely, if the patient is assessed with Stage 1
or Stage 2, PCUs remain in charge of COPD management.
PCUs must also provide a Counseling service in order to edu-
cate patients to avoid exposure to behaviors that can further
compromise their health condition. The progression of the
disease can be limited by efficient monitoring and changes in
lifestyle and smoking habits. In the final stage of COPD as-
sessment, the general practitioner needs to Schedule dietitian
consultation if the patient presents a BMI greater than 30.
Finally, he/she has to Plan vaccinations (influenza and pneu-
mococcus), as they appear to be effective in older and severe
patients [23]. Once the main steps of the care intervention
have been scheduled, the COPD diagnosis and assessment
process terminates.
A.2 Ordinary management of stable COPD
Life-long and continuous management of stable COPD can
become quite complex especially in advanced stages of the
disease, as multiple complications have to be considered be-
side compromised pulmonary function. In particular, patients
affected by COPD suffer from impaired gas exchange and are
subjected to develop cardiovascular, metabolic, and neoplas-
tic comorbidities [23].
Therefore, COPD treatment aims to prevent the progres-
sion of the disease, relieve patient symptoms, improve ex-
ercise tolerance and general health status, and prevent and
treat correlated complications. The type of care workers in
charge of COPD management and the frequency of medical
inspections depend on the severity of the disease, on the pa-
tient individual response to pharmacological treatment, and
on the healthcare system. Ordinary management of COPD
encompasses the following important aspects: smoking ces-
sation, optimization of pulmonary status by pharmacological
therapy, improvement of exercise tolerance, nutritional care,
and possible support in terms of oxygen therapy or pulmonary
ventilation. Besides, education, social, and behavioral aspects
must be considered to improve compliance [56]. Vaccinations
can be required, based on local policies, availability, and af-
fordability [23]. Influenza and pneumococcal vaccinations are
planned yearly, to prevent the insurgence of serious illnesses
that may contribute to COPD exacerbations.
Ordinary management of COPD is based on individual-
ized assessment and aims to reduce both current symptoms
and risk of sudden worsening [23]. As previously mentioned,
the BPMN diagram representing the main steps of ordinary
management of COPD, depicted in Fig. 7, is executed with
a periodicity that depends on assessed COPD stage. This
periodicity is captured by a start timer event. Specifically,
the process is expected to start every two years for patients
in Stage 1, every year for patients in Stage 2 and every six
months or less for patients in Stage 3.
The first steps of the care process are executed either by
the general practitioner, for patients in Stage 1 and 2, or by
the pulmonologist, for patients in Stage 3, but the conduct
of the explained actions coincides. Firstly, it is necessary to
Verify administered vaccinations. In the studied context, vac-
cinations are managed by district health authorities. If vacci-
nations have not been administered, the physician must Re-
schedule vaccinations. If the patient refuses to be vaccinated,
the motivation behind the refusal must be recorded in the
health authority information system HC district db. In the
studied context, data suggest that elderly patients often for-
get to attend vaccination appointments or they have troubles
reaching care facilities, due to mobility limitations. In this
latter case, vaccinations can be provided at home, depending
on local service availability.
To monitor the disease, care providers are required to
Administer COPD Assessment Test (CAT) and to Adjust cur-
rent bronchodilator therapy, if needed. Pharmacological ther-
apy is prescribed according to the severity of the illness, the
availability of the drugs, and the presence of comorbidities.
Treatment regimen should be patient-specific as the relation-
ship between the severity of symptoms and airflow obstruc-
tion tends to vary from patient to patient, Moreover, COPD
severity is also dependent on the geographical distribution
of the population. Usually, patients in Stage 1 are treated
with short-acting inhaled bronchodilators, whilst long-acting
bronchodilators are prescribed to patients in Stage 2 or 3, in
different dosage and combinations.
Then, different inspections are carried out in parallel, to
evaluate the patient’s health status, and re-assess BMI and
respiratory function. Mondor and Fagerstörm tests are ad-
ministered in order to Evaluate lifestyle and smoking habits,
with the aim to assess the patient’s progress towards smoking
cessation. Physicians must also Evaluate dyspnea and exercise
tolerance. The objective measurement of exercise impairment
is obtained with the help of the 6-Minute Walk Test [22]. This
is used in conjunction with the Modified British Medical Re-
search Council (mMRC) dyspnea questionnaire to quantify
the degree of disability due to breathlessness during daily ac-
tivities. Body Mass Index (BMI) must also be re-assessed, in
order to decide if it is necessary to Prescribe a dietitian consul-
tation. Obesity and weight loss, when combined with muscle
wasting, contribute significantly to morbidity, disability, and
handicap in COPD patients, who must receive nutritional
therapy. Pulse oximetry is used to evaluate oxygen saturation.
If the measured oxygen saturation is less than 92%, blood gas
assessment is scheduled. Arterial Blood Gas Analysis (ABG) is
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the preferred method for determining the need of oxygen ther-
apy [56]. Finally, the patient is examined and all analyses re-
sults are resumed and recorded in the dedicated information
system PCU db.
If the patient is assessed with Stage 2 or Stage 3, he/she
might necessitate an additional pulmonary inspection. In this
case, a pulmonologist can Request Oxygen Therapy according
to the considered clinical picture. Long-term oxygen therapy
is usually administered continuously and in a home-care set-
ting to improve survival, exercise, sleep, and cognitive perfor-
mance. In addition, a cardiological consult may be requested,
to exclude cardiovascular instability. Finally, the pulmonolo-
gist must Review COPD stage in order to confirm the stage
after treatment or to update it. At the end of each instance of
the COPD ordinary management process, the general prac-
titioner must either Confirm COPD stage or Update COPD
stage, if this has changed. In case of stage change, signal event
Re-schedule is thrown to be caught by the corresponding in-
terrupting boundary event, depicted in Fig. 5 and attached
to the border of sub-process Management of COPD Exacerba-
tions.
The introduced healthcare process representing the ordi-
nary management of stable COPD is periodically re-enacted
and the patient is also involved in educational programs to
improve recognition of symptoms worsening and self-care.
A.3 Management of COPD Exacerbations
COPD exacerbations are “acute episodes characterized by a
sudden worsening of the patient respiratory symptoms that
is beyond expected day-to-day variations” [108]. The main
drawback associated with COPD exacerbations is represented
by hospital admissions, that negatively impact the disease
evolution, economical costs, and quality of life [66].
Several clinical findings must be considered when evalu-
ating patients with exacerbations. Among these COPD sever-
ity, the presence of comorbidities, and the history of previous
exacerbations are the most important. Indeed, patients that
are subjected to two or more exacerbations of COPD per year
seem to maintain this worsening trend over time and, thus,
must be constantly monitored. A diagnosis of exacerbation
requires a physical examination to evaluate the effects of the
episode on both cardiovascular and respiratory systems [23].
COPD exacerbations are often treated with temporary
short-acting inhaled beta2-agonists, which can be combined
with corticosteroids and antibiotics. However, if the patient
does not respond to outpatient pharmacological treatment,
hospitalization is required. When a patient is admitted to
hospital, supplementary oxygen is administered, short-acting
bronchodilators are prescribed, and pulmonary rehabilitation
may also be indicated [56].
COPD hospital admissions due to exacerbations nega-
tively affect the patient quality of life and the progression
of the illness, while substantially increasing the costs of pa-
tient management [66]. However, a standardized and inte-
grated care intervention, supported by proper data collection
and resource coordination, seems to effectively prevent hospi-
talizations due to exacerbations in COPD patients [66,109].
The goal of exacerbation treatment is to minimize the ef-
fects of the on-going worsening and prevent future episodes.
The process enacted for treating COPD exacerbations in Veneto
is depicted in Fig. 8.
An exacerbation episode is usually detected by the Gen-
eral Practitioner, following the clinical presentation of the pa-
tient, who complains of an acute change of symptoms. Diag-
nosis of exacerbation relies on the current symptoms, on the
evidence gathered during the Physical examination with pulse
oximetry, and on the history of previous worsening episodes.
If more than two exacerbations occur within one year, the
stage of the disease is expected to vary, as the patient respi-
ratory function is compromised more rapidly [56]. In general,
diagnosing an exacerbation can become quite cumbersome,
as multiple physical findings and diagnostic procedures must
be evaluated, with the main aim of excluding the develop-
ment of comorbidities. If oxygen saturation measured with
pulse oximetry is <90%, the exacerbation is likely to be life-
threatening and, thus, hospital and intensive care treatment
is indicated. Otherwise, the general practitioner can Suspend
current therapy in order to Begin therapy to oppose worsen-
ing. Usually, short acting beta agonists (SABA), short act-
ing muscarinic antagonists (SAMA), inhaled corticosteroids
and antibiotics are prescribed, according to the considered
clinical picture. Then, after 24/48 hours the patient is re-
evaluated. Following clinical diagnosis, gateway Is exacerba-
tion life-threatening? determines if the patient needs to be
treated in inpatient or outpatient settings. If the patient has
improved, the exacerbation can be managed in an outpa-
tient setting. In these circumstances, it is indicated to Con-
tinue with current therapy and to Schedule periodic examina-
tions to ensure proper patient monitoring. If the patient has
not improved after treatment or oxygen saturation is assessed
<90%, he/she is sent to the hospital Emergency Room. Hospi-
talization must be considered when the patient cannot been
treated adequately in home care settings, due to the sever-
ity of the respiratory dysfunction [23,56]. Following ER triage,
ER physicians must Test hydration level to ensure proper fluid
balance and they need to Assess symptoms. Then, the patient
is physically examined and continuously monitored. Physi-
cians in ER must exclude other clinical complications, such
as heart failure, bronchial pneumonia, pulmonary embolism,
and pleural effusion. A Pulmonologist examination in ICU can
be requested to assess arterial blood gases and execute chest
radiography. If the severity of respiratory dysfunction is high,
the patient must be admitted to an intensive care unit and
treated under the responsibility of a pulmonologist. Different
factors must be considered when evaluating hospitalization.
Typically, patients are admitted in ICU when COPD symp-
toms are acute, there is a preponderance of sensory distur-
bances, there is evidence of new cardiac arrhythmia, or no re-
sponse to exacerbation treatment is observed [23]. The Treat-
ment to solve exacerbation is mostly based on oxygen therapy,
which aims to prevent tissue hypoxaemia, i.e., reduced oxy-
gen availability, and at preserving cellular oxygenation. Dur-
ing hospitalization, the General Practitioner is informed about
the administered care. This is necessary to provide practition-
ers with all the information, needed to optimally treat the
patient after hospital discharge. Patient discharge is decided
after evaluating several criteria, which consider also local poli-
cies and availability. The discharge report must contain infor-
mation regarding the possibly changed COPD stage, respi-
ratory function, comorbidities, outpatient suggested therapy,
and clinical follow-up. Patients dismissed with hypoxaemia or
in Stage 3 may require short-term or long-term oxygen ther-
apy. In this case, a pulmonologist must Take the patient in
charge and a home-care oxygen therapy protocol is started.
Oxygen therapy is monitored by specialized centers in the
region and its efficacy must be re-evaluated yearly.
As required by the national program for the evaluation
of care outcomes, two weeks after patient discharge, the gen-
eral practitioner must Verify treatment efficacy and effective-
ness. The aforementioned evaluation program aims to esti-
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mate the overall quality of the provided care, in terms of treat-
ment costs, appropriateness, and efficacy, in order to compare
the outcomes of the overall care intervention with audit and
bench-marking data. Hospital re-admission of COPD patients
within 30 days from discharge is probably the most impor-
tant indicator used for assessing the quality of the overall
care plan [66, 110]. In the studied context, around 15% of
discharged patients is re-hospitalized within 30 days from
discharge. During this final verification phase, the stage of
COPD is also reviewed and, if it has changed as a conse-
quence of the exacerbation, signal State changed is thrown.
This is caught by the corresponding non-interrupting bound-
ary event attached to the border of sub-process Management
of COPD Exacerbation of Fig. 5, which enables an exception
flow devoted to the rescheduling ordinary examinations. Like-
wise ordinary management of COPD, exacerbations require
follow-up. This includes reassessment within 4 weeks, eval-
uation of improvement in symptoms, physical examination,
assessment of need for oxygen therapy, and re-adjustment of
current treatment regimen.
